Tag: Nursing

  • [Solved] FNP ADLT D6 REP

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    In-depth study guidance and analytical solution covering FNP ADLT D6 REP.

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Full assignment prompt and step-by-step guidance are included in the downloadable solution file.

  • [Solved] Research project

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    – ## Extrainstruccionsforpresetation.docx – ## RevisedOutline-PE.pdf **## Extrainstruccionsforpresetation.docx** · When deciding on references, consider whether the **journal is high impact**. References should also be within the last 5 years. · References should be more related to practice guidelin…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    – ## Extrainstruccionsforpresetation.docx

    – ## RevisedOutline-PE.pdf

    **## Extrainstruccionsforpresetation.docx**

    · When deciding on references, consider whether the
    **journal is high impact**. References should also be within the last 5 years.

    · References should be more related to practice guidelines and not clinical trials. We want to make sure that the presentation is clear on how to diagnose and treat PE related to current standards of practice. See below some links that may help.

    ·
    [https://pmc.ncbi.nlm.nih.gov/articles/PMC7284001/](https://pmc.ncbi.nlm.nih.gov/articles/PMC7284001/)

    ·
    [https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/treatment](https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/treatment)

    ·
    [https://www.ncbi.nlm.nih.gov/books/NBK560551/](https://www.ncbi.nlm.nih.gov/books/NBK560551/)

    ·
    [https://www.nejm.org/doi/full/10.1056/NEJMcp2116489](https://www.nejm.org/doi/full/10.1056/NEJMcp2116489)

    · Often times a hematologist will be consulted to see a patient with newly diagnosed DVT or PE. This would be a good source to reference from the American Society of Hematology.

    · Add 2 slides to the outline:

    · Comparison of prior standards for diagnosing and treating PEs. Remember our audience will be practitioners in practice with 20+ years and novice practitioners.

    · Populations for Special Considerations for treating PEs

    · What happens if a patient cannot be treated with Heparin, etc? The standard treatments.

    · Are there special considerations for cancer patients, older adults, etc.

    · Add treatment education for patients.

    **## RevisedOutline-PE.pdf**

    Slide 1: Title Slide
    A. Title: Diagnosis & Management of Pulmonary Embolism
    B. Presenter’s name and credentials
    C. Date and audience
    Slide 2: Introduction
    A. Purpose: Enhance NP skills in PE diagnosis and management
    B. Overview: Covers epidemiology, diagnosis, treatment, and NP role
    C. Importance: Improve patient outcomes in acute care
    Slide 3: Significance of PE
    A. Definition of pulmonary embolism
    B. Impact on morbidity and mortality
    C. Relevance to NP practice
    Slide 4: Epidemiology: Incidence
    A. Global and regional incidence rates
    B. Prevalence in acute care settings
    C. Public health implications
    Slide 5: Epidemiology: Demographics
    A. Age, gender, and ethnicity trends
    B. High-risk patient groups
    C. NP demographic awareness
    Slide 6: Risk Factors: Primary
    A. Immobility, surgery, and trauma
    B. Hospitalization-related risks
    C. NP risk screening techniques
    Slide 7: Risk Factors: Secondary
    A. Malignancy, pregnancy, and hormonal therapy
    B. Genetic and chronic conditions
    C. NP history-taking focus
    Slide 8: Pathophysiology: Thrombus Formation
    A. Process of clot development
    B. Link to venous thromboembolism
    C. Clinical relevance
    Slide 9: Pathophysiology: Systemic Impact
    A. Effects on pulmonary circulation
    B. Cardiac and hemodynamic consequences
    C. NP care implications
    Slide 10: Clinical Symptoms: Common
    A. Dyspnea, chest pain, tachycardia
    B. Hypoxia and respiratory distress
    C. NP symptom identification
    Slide 11: Clinical Symptoms: Atypical
    A. Syncope, fatigue, and vague symptoms

    B. Challenges in atypical cases
    C. NP vigilance
    Slide 12: Physical Assessment: Core Techniques
    A. Vital signs and oxygen saturation
    B. Respiratory system evaluation
    C. NP exam fundamentals
    Slide 13: Physical Assessment: Specialized Findings
    A. Cardiac signs and peripheral edema
    B. Lung auscultation specifics
    C. NP documentation skills
    Slide 14: Clinical Decision Tools: Wells Score
    A. Components and scoring
    B. Probability assessment
    C. NP application in practice
    Slide 15: Clinical Decision Tools: Geneva Score
    A. Revised Geneva Score overview
    B. Use in acute settings
    C. NP decision-making aid
    Slide 16: Laboratory Tests: D-dimer
    A. Role in ruling out PE
    B. Test limitations and specificity
    C. NP interpretation
    Slide 17: Laboratory Tests: Additional Markers
    A. Troponin, BNP, and ABG
    B. Supporting diagnostic process
    C. NP result integration
    Slide 18: Imaging: CT Pulmonary Angiography
    A. Gold standard for PE diagnosis
    B. Procedure and indications
    C. NP coordination role
    Slide 19: Imaging: V/Q Scan
    A. Alternative imaging option
    B. Indications and limitations
    C. NP imaging decisions
    Slide 20: Diagnostic Standards: New vs Old
    A. Discuss historical standard for imaging and PE diagnosis
    B. Discuss new gold-standard for imaging and PE diagnosis
    C. Discuss reasons for change in standard
    Slide 21: Diagnostic Workflow
    A. Stepwise PE diagnostic approach
    B. Combining clinical and test data
    C. NP efficiency in diagnosis

    Slide 22: Anticoagulation: First-Line Therapy
    A. Low-molecular-weight heparin, DOACs
    B. Dosing and administration
    C. NP treatment initiation
    Slide 23: Anticoagulation: Monitoring
    A. Bleeding risk and side effects
    B. Lab monitoring requirements
    C. NP patient oversight
    Slide 24: Thrombolytic Therapy
    A. Indications for high-risk PE
    B. Risks and contraindications
    C. NP role in critical care
    Slide 25: Non-Pharmacologic: Supportive Care
    A. Oxygen therapy and ventilation
    B. Hemodynamic stabilization
    C. NP care planning
    Slide 26: Non-Pharmacologic: IVC Filters
    A. Indications and procedure
    B. Follow-up and complications
    C. NP involvement
    Slide 27: Special Populations:
    A. Pregnancy & Postpartum
    B. Children & VTE
    Slide 28: Special Populations:
    A. Discuss clinical presentation, diagnostic workup, treatment
    B. Follow-up and long-term management
    Slide 29: Decision Tree for PE
    A. attach image of decision tree
    Slide 30: Patient Education: Treatment Adherence
    A. Importance of medication compliance
    B. Recognizing adverse effects
    C. NP education strategies
    Slide 31: Patient Education: Lifestyle Changes
    A. Activity, diet, and risk reduction
    B. Long-term health strategies
    C. NP counseling techniques
    Slide 32: Follow-Up Care
    A. Anticoagulation duration and monitoring
    B. Scheduling follow-up visits
    C. NP role in continuity

    Slide 33: Complications and Prevention
    A. Chronic thromboembolic disease, recurrence
    B. Thromboprophylaxis and risk stratification
    C. NP advocacy for prevention
    Slide 34: Conclusion and Q&A
    A. Summary of key points
    B. NP impact on PE outcomes
    C. Open floor for questions
    Slide 35: References
    Chopard, R., Behr, J., Vidoni, C., Ecarnot, F., & Meneveau, N. (2022).
    An update on the management of acute high-risk pulmonary
    embolism. Journal of Clinical Medicine, 11(16), 4807.
    https://doi.org/10.3390/jcm11164807

    de Wit, K., & D’Arsigny, C. L. (2023). Risk stratification of acute pulmonary
    embolism. Journal of Thrombosis and Haemostasis, 21(11),
    3016-3023.
    https://doi.org/10.1016/j.jtha.2023.05.003

    Duffy, J., Berger, F. H., Cheng, I., Shelton, D., Galanaud, J. P., Selby, R.,
    … & Hall, J. (2023). Implementation of the YEARS algorithm to
    optimise pulmonary embolism diagnostic workup in the emergency
    department. BMJ Open Quality, 12(2), e002119.
    https://bmjopenquality.bmj.com/content/12/2/e002119

    Højen, A. A., Nielsen, P. B., Overvad, T. F., Albertsen, I. E., Klok, F. A.,
    Rolving, N., … & Ording, A. G. (2022). Long-term management of
    pulmonary embolism: a review of consequences, treatment, and
    rehabilitation. Journal of Clinical Medicine, 11(19), 5970.

    https://doi.org/10.3390/jcm11195970

    Khan, F., Tritschler, T., Kahn, S. R., & Rodger, M. A. (2021). Venous
    thromboembolism. The lancet, 398(10294), 64-77.
    https://www.thelancet.com/article/S0140-6736(20)32658- 1/abstract

    Kulka, H. C., Zeller, A., Fornaro, J., Wuillemin, W. A., Konstantinides, S.,
    & Christ, M. (2021). Acute Pulmonary Embolism: its diagnosis and
    treatment from a multidisciplinary viewpoint. Deutsches Ärzteblatt
    international, 118(37), 618.
    https://doi.org/10.3238/arztebl.m2021.0226

    Monteleone, P., Ahern, R., Banerjee, S., Desai, K. R., Kadian-Dodov, D.,
    Webber, E., … & Parikh, S. A. (2024). Modern treatment of pulmonary
    embolism (USCDT vs MT): results from a real-world, big data
    analysis (REAL-PE). Journal of the Society for Cardiovascular
    Angiography & Interventions, 3(1), 101192.
    https://doi.org/10.1016/j.jscai.2023.101192

    Murthi, M., Velagapudi, S., Park, D. Y., & Shaka, H. (2022). Pulmonary
    embolism readmission trend over the years (from a National
    Readmission Database). The American journal of cardiology, 184,

    133-140. https://doi.org/10.1016/j.amjcard.2022.08.025

    Visconti, L., Celi, A., Carrozzi, L., Tinelli, C., Crocetti, L., Daviddi, F., … &
    Pancani, R. (2024). Inferior vena cava filters: Concept review and
    summary of current guidelines. Vascular Pharmacology, 107375.
    https://doi.org/10.1016/j.vph.2024.107375

    Vrettou, C. S., Dima, E., & Sigala, I. (2024). Pulmonary Embolism in
    Critically Ill Patients— Prevention, Diagnosis, and Management.
    Diagnostics, 14(19), 2208.

    https://doi.org/10.3390/diagnostics14192208

    **## RevisedOutline-PE.pdf**

    Slide 1: Title Slide
    A. Title: Diagnosis & Management of Pulmonary Embolism
    B. Presenter’s name and credentials
    C. Date and audience
    Slide 2: Introduction
    A. Purpose: Enhance NP skills in PE diagnosis and management
    B. Overview: Covers epidemiology, diagnosis, treatment, and NP role
    C. Importance: Improve patient outcomes in acute care
    Slide 3: Significance of PE
    A. Definition of pulmonary embolism
    B. Impact on morbidity and mortality
    C. Relevance to NP practice
    Slide 4: Epidemiology: Incidence
    A. Global and regional incidence rates
    B. Prevalence in acute care settings
    C. Public health implications
    Slide 5: Epidemiology: Demographics
    A. Age, gender, and ethnicity trends
    B. High-risk patient groups
    C. NP demographic awareness
    Slide 6: Risk Factors: Primary
    A. Immobility, surgery, and trauma
    B. Hospitalization-related risks
    C. NP risk screening techniques
    Slide 7: Risk Factors: Secondary
    A. Malignancy, pregnancy, and hormonal therapy
    B. Genetic and chronic conditions
    C. NP history-taking focus
    Slide 8: Pathophysiology: Thrombus Formation
    A. Process of clot development
    B. Link to venous thromboembolism
    C. Clinical relevance
    Slide 9: Pathophysiology: Systemic Impact
    A. Effects on pulmonary circulation
    B. Cardiac and hemodynamic consequences
    C. NP care implications
    Slide 10: Clinical Symptoms: Common
    A. Dyspnea, chest pain, tachycardia
    B. Hypoxia and respiratory distress
    C. NP symptom identification
    Slide 11: Clinical Symptoms: Atypical
    A. Syncope, fatigue, and vague symptoms

    B. Challenges in atypical cases
    C. NP vigilance
    Slide 12: Physical Assessment: Core Techniques
    A. Vital signs and oxygen saturation
    B. Respiratory system evaluation
    C. NP exam fundamentals
    Slide 13: Physical Assessment: Specialized Findings
    A. Cardiac signs and peripheral edema
    B. Lung auscultation specifics
    C. NP documentation skills
    Slide 14: Clinical Decision Tools: Wells Score
    A. Components and scoring
    B. Probability assessment
    C. NP application in practice
    Slide 15: Clinical Decision Tools: Geneva Score
    A. Revised Geneva Score overview
    B. Use in acute settings
    C. NP decision-making aid
    Slide 16: Laboratory Tests: D-dimer
    A. Role in ruling out PE
    B. Test limitations and specificity
    C. NP interpretation
    Slide 17: Laboratory Tests: Additional Markers
    A. Troponin, BNP, and ABG
    B. Supporting diagnostic process
    C. NP result integration
    Slide 18: Imaging: CT Pulmonary Angiography
    A. Gold standard for PE diagnosis
    B. Procedure and indications
    C. NP coordination role
    Slide 19: Imaging: V/Q Scan
    A. Alternative imaging option
    B. Indications and limitations
    C. NP imaging decisions
    Slide 20: Diagnostic Standards: New vs Old
    A. Discuss historical standard for imaging and PE diagnosis
    B. Discuss new gold-standard for imaging and PE diagnosis
    C. Discuss reasons for change in standard
    Slide 21: Diagnostic Workflow
    A. Stepwise PE diagnostic approach
    B. Combining clinical and test data
    C. NP efficiency in diagnosis

    Slide 22: Anticoagulation: First-Line Therapy
    A. Low-molecular-weight heparin, DOACs
    B. Dosing and administration
    C. NP treatment initiation
    Slide 23: Anticoagulation: Monitoring
    A. Bleeding risk and side effects
    B. Lab monitoring requirements
    C. NP patient oversight
    Slide 24: Thrombolytic Therapy
    A. Indications for high-risk PE
    B. Risks and contraindications
    C. NP role in critical care
    Slide 25: Non-Pharmacologic: Supportive Care
    A. Oxygen therapy and ventilation
    B. Hemodynamic stabilization
    C. NP care planning
    Slide 26: Non-Pharmacologic: IVC Filters
    A. Indications and procedure
    B. Follow-up and complications
    C. NP involvement
    Slide 27: Special Populations:
    A. Pregnancy & Postpartum
    B. Children & VTE
    Slide 28: Special Populations:
    A. Discuss clinical presentation, diagnostic workup, treatment
    B. Follow-up and long-term management
    Slide 29: Decision Tree for PE
    A. attach image of decision tree
    Slide 30: Patient Education: Treatment Adherence
    A. Importance of medication compliance
    B. Recognizing adverse effects
    C. NP education strategies
    Slide 31: Patient Education: Lifestyle Changes
    A. Activity, diet, and risk reduction
    B. Long-term health strategies
    C. NP counseling techniques
    Slide 32: Follow-Up Care
    A. Anticoagulation duration and monitoring
    B. Scheduling follow-up visits
    C. NP role in continuity

    Slide 33: Complications and Prevention
    A. Chronic thromboembolic disease, recurrence
    B. Thromboprophylaxis and risk stratification
    C. NP advocacy for prevention
    Slide 34: Conclusion and Q&A
    A. Summary of key points
    B. NP impact on PE outcomes
    C. Open floor for questions
    Slide 35: References
    Chopard, R., Behr, J., Vidoni, C., Ecarnot, F., & Meneveau, N. (2022).
    An update on the management of acute high-risk pulmonary
    embolism. Journal of Clinical Medicine, 11(16), 4807.
    https://doi.org/10.3390/jcm11164807

    de Wit, K., & D’Arsigny, C. L. (2023). Risk stratification of acute pulmonary
    embolism. Journal of Thrombosis and Haemostasis, 21(11),
    3016-3023.
    https://doi.org/10.1016/j.jtha.2023.05.003

    Duffy, J., Berger, F. H., Cheng, I., Shelton, D., Galanaud, J. P., Selby, R.,
    … & Hall, J. (2023). Implementation of the YEARS algorithm to
    optimise pulmonary embolism diagnostic workup in the emergency
    department. BMJ Open Quality, 12(2), e002119.
    https://bmjopenquality.bmj.com/content/12/2/e002119

    Højen, A. A., Nielsen, P. B., Overvad, T. F., Albertsen, I. E., Klok, F. A.,
    Rolving, N., … & Ording, A. G. (2022). Long-term management of
    pulmonary embolism: a review of consequences, treatment, and
    rehabilitation. Journal of Clinical Medicine, 11(19), 5970.

    https://doi.org/10.3390/jcm11195970

    Khan, F., Tritschler, T., Kahn, S. R., & Rodger, M. A. (2021). Venous
    thromboembolism. The lancet, 398(10294), 64-77.
    https://www.thelancet.com/article/S0140-6736(20)32658- 1/abstract

    Kulka, H. C., Zeller, A., Fornaro, J., Wuillemin, W. A., Konstantinides, S.,
    & Christ, M. (2021). Acute Pulmonary Embolism: its diagnosis and
    treatment from a multidisciplinary viewpoint. Deutsches Ärzteblatt
    international, 118(37), 618.
    https://doi.org/10.3238/arztebl.m2021.0226

    Monteleone, P., Ahern, R., Banerjee, S., Desai, K. R., Kadian-Dodov, D.,
    Webber, E., … & Parikh, S. A. (2024). Modern treatment of pulmonary
    embolism (USCDT vs MT): results from a real-world, big data
    analysis (REAL-PE). Journal of the Society for Cardiovascular
    Angiography & Interventions, 3(1), 101192.
    https://doi.org/10.1016/j.jscai.2023.101192

    Murthi, M., Velagapudi, S., Park, D. Y., & Shaka, H. (2022). Pulmonary
    embolism readmission trend over the years (from a National
    Readmission Database). The American journal of cardiology, 184,

    133-140. https://doi.org/10.1016/j.amjcard.2022.08.025

    Visconti, L., Celi, A., Carrozzi, L., Tinelli, C., Crocetti, L., Daviddi, F., … &
    Pancani, R. (2024). Inferior vena cava filters: Concept review and
    summary of current guidelines. Vascular Pharmacology, 107375.
    https://doi.org/10.1016/j.vph.2024.107375

    Vrettou, C. S., Dima, E., & Sigala, I. (2024). Pulmonary Embolism in
    Critically Ill Patients— Prevention, Diagnosis, and Management.
    Diagnostics, 14(19), 2208.

    https://doi.org/10.3390/diagnostics14192208

    **## Extrainstruccionsforpresetation.docx**

    · When deciding on references, consider whether the
    **journal is high impact**. References should also be within the last 5 years.

    · References should be more related to practice guidelines and not clinical trials. We want to make sure that the presentation is clear on how to diagnose and treat PE related to current standards of practice. See below some links that may help.

    ·
    [https://pmc.ncbi.nlm.nih.gov/articles/PMC7284001/](https://pmc.ncbi.nlm.nih.gov/articles/PMC7284001/)

    ·
    [https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/treatment](https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/treatment)

    ·
    [https://www.ncbi.nlm.nih.gov/books/NBK560551/](https://www.ncbi.nlm.nih.gov/books/NBK560551/)

    ·
    [https://www.nejm.org/doi/full/10.1056/NEJMcp2116489](https://www.nejm.org/doi/full/10.1056/NEJMcp2116489)

    · Often times a hematologist will be consulted to see a patient with newly diagnosed DVT or PE. This would be a good source to reference from the American Society of Hematology.

    · Add 2 slides to the outline:

    · Comparison of prior standards for diagnosing and treating PEs. Remember our audience will be practitioners in practice with 20+ years and novice practitioners.

    · Populations for Special Considerations for treating PEs

    · What happens if a patient cannot be treated with Heparin, etc? The standard treatments.

    · Are there special considerations for cancer patients, older adults, etc.

    · Add treatment education for patients.

    **## RevisedOutline-PE.pdf**

    Slide 1: Title Slide
    A. Title: Diagnosis & Management of Pulmonary Embolism
    B. Presenter’s name and credentials
    C. Date and audience
    Slide 2: Introduction
    A. Purpose: Enhance NP skills in PE diagnosis and management
    B. Overview: Covers epidemiology, diagnosis, treatment, and NP role
    C. Importance: Improve patient outcomes in acute care
    Slide 3: Significance of PE
    A. Definition of pulmonary embolism
    B. Impact on morbidity and mortality
    C. Relevance to NP practice
    Slide 4: Epidemiology: Incidence
    A. Global and regional incidence rates
    B. Prevalence in acute care settings
    C. Public health implications
    Slide 5: Epidemiology: Demographics
    A. Age, gender, and ethnicity trends
    B. High-risk patient groups
    C. NP demographic awareness
    Slide 6: Risk Factors: Primary
    A. Immobility, surgery, and trauma
    B. Hospitalization-related risks
    C. NP risk screening techniques
    Slide 7: Risk Factors: Secondary
    A. Malignancy, pregnancy, and hormonal therapy
    B. Genetic and chronic conditions
    C. NP history-taking focus
    Slide 8: Pathophysiology: Thrombus Formation
    A. Process of clot development
    B. Link to venous thromboembolism
    C. Clinical relevance
    Slide 9: Pathophysiology: Systemic Impact
    A. Effects on pulmonary circulation
    B. Cardiac and hemodynamic consequences
    C. NP care implications
    Slide 10: Clinical Symptoms: Common
    A. Dyspnea, chest pain, tachycardia
    B. Hypoxia and respiratory distress
    C. NP symptom identification
    Slide 11: Clinical Symptoms: Atypical
    A. Syncope, fatigue, and vague symptoms

    B. Challenges in atypical cases
    C. NP vigilance
    Slide 12: Physical Assessment: Core Techniques
    A. Vital signs and oxygen saturation
    B. Respiratory system evaluation
    C. NP exam fundamentals
    Slide 13: Physical Assessment: Specialized Findings
    A. Cardiac signs and peripheral edema
    B. Lung auscultation specifics
    C. NP documentation skills
    Slide 14: Clinical Decision Tools: Wells Score
    A. Components and scoring
    B. Probability assessment
    C. NP application in practice
    Slide 15: Clinical Decision Tools: Geneva Score
    A. Revised Geneva Score overview
    B. Use in acute settings
    C. NP decision-making aid
    Slide 16: Laboratory Tests: D-dimer
    A. Role in ruling out PE
    B. Test limitations and specificity
    C. NP interpretation
    Slide 17: Laboratory Tests: Additional Markers
    A. Troponin, BNP, and ABG
    B. Supporting diagnostic process
    C. NP result integration
    Slide 18: Imaging: CT Pulmonary Angiography
    A. Gold standard for PE diagnosis
    B. Procedure and indications
    C. NP coordination role
    Slide 19: Imaging: V/Q Scan
    A. Alternative imaging option
    B. Indications and limitations
    C. NP imaging decisions
    Slide 20: Diagnostic Standards: New vs Old
    A. Discuss historical standard for imaging and PE diagnosis
    B. Discuss new gold-standard for imaging and PE diagnosis
    C. Discuss reasons for change in standard
    Slide 21: Diagnostic Workflow
    A. Stepwise PE diagnostic approach
    B. Combining clinical and test data
    C. NP efficiency in diagnosis

    Slide 22: Anticoagulation: First-Line Therapy
    A. Low-molecular-weight heparin, DOACs
    B. Dosing and administration
    C. NP treatment initiation
    Slide 23: Anticoagulation: Monitoring
    A. Bleeding risk and side effects
    B. Lab monitoring requirements
    C. NP patient oversight
    Slide 24: Thrombolytic Therapy
    A. Indications for high-risk PE
    B. Risks and contraindications
    C. NP role in critical care
    Slide 25: Non-Pharmacologic: Supportive Care
    A. Oxygen therapy and ventilation
    B. Hemodynamic stabilization
    C. NP care planning
    Slide 26: Non-Pharmacologic: IVC Filters
    A. Indications and procedure
    B. Follow-up and complications
    C. NP involvement
    Slide 27: Special Populations:
    A. Pregnancy & Postpartum
    B. Children & VTE
    Slide 28: Special Populations:
    A. Discuss clinical presentation, diagnostic workup, treatment
    B. Follow-up and long-term management
    Slide 29: Decision Tree for PE
    A. attach image of decision tree
    Slide 30: Patient Education: Treatment Adherence
    A. Importance of medication compliance
    B. Recognizing adverse effects
    C. NP education strategies
    Slide 31: Patient Education: Lifestyle Changes
    A. Activity, diet, and risk reduction
    B. Long-term health strategies
    C. NP counseling techniques
    Slide 32: Follow-Up Care
    A. Anticoagulation duration and monitoring
    B. Scheduling follow-up visits
    C. NP role in continuity

    Slide 33: Complications and Prevention
    A. Chronic thromboembolic disease, recurrence
    B. Thromboprophylaxis and risk stratification
    C. NP advocacy for prevention
    Slide 34: Conclusion and Q&A
    A. Summary of key points
    B. NP impact on PE outcomes
    C. Open floor for questions
    Slide 35: References
    Chopard, R., Behr, J., Vidoni, C., Ecarnot, F., & Meneveau, N. (2022).
    An update on the management of acute high-risk pulmonary
    embolism. Journal of Clinical Medicine, 11(16), 4807.
    https://doi.org/10.3390/jcm11164807

    de Wit, K., & D’Arsigny, C. L. (2023). Risk stratification of acute pulmonary
    embolism. Journal of Thrombosis and Haemostasis, 21(11),
    3016-3023.
    https://doi.org/10.1016/j.jtha.2023.05.003

    Duffy, J., Berger, F. H., Cheng, I., Shelton, D., Galanaud, J. P., Selby, R.,
    … & Hall, J. (2023). Implementation of the YEARS algorithm to
    optimise pulmonary embolism diagnostic workup in the emergency
    department. BMJ Open Quality, 12(2), e002119.
    https://bmjopenquality.bmj.com/content/12/2/e002119

    Højen, A. A., Nielsen, P. B., Overvad, T. F., Albertsen, I. E., Klok, F. A.,
    Rolving, N., … & Ording, A. G. (2022). Long-term management of
    pulmonary embolism: a review of consequences, treatment, and
    rehabilitation. Journal of Clinical Medicine, 11(19), 5970.

    https://doi.org/10.3390/jcm11195970

    Khan, F., Tritschler, T., Kahn, S. R., & Rodger, M. A. (2021). Venous
    thromboembolism. The lancet, 398(10294), 64-77.
    https://www.thelancet.com/article/S0140-6736(20)32658- 1/abstract

    Kulka, H. C., Zeller, A., Fornaro, J., Wuillemin, W. A., Konstantinides, S.,
    & Christ, M. (2021). Acute Pulmonary Embolism: its diagnosis and
    treatment from a multidisciplinary viewpoint. Deutsches Ärzteblatt
    international, 118(37), 618.
    https://doi.org/10.3238/arztebl.m2021.0226

    Monteleone, P., Ahern, R., Banerjee, S., Desai, K. R., Kadian-Dodov, D.,
    Webber, E., … & Parikh, S. A. (2024). Modern treatment of pulmonary
    embolism (USCDT vs MT): results from a real-world, big data
    analysis (REAL-PE). Journal of the Society for Cardiovascular
    Angiography & Interventions, 3(1), 101192.
    https://doi.org/10.1016/j.jscai.2023.101192

    Murthi, M., Velagapudi, S., Park, D. Y., & Shaka, H. (2022). Pulmonary
    embolism readmission trend over the years (from a National
    Readmission Database). The American journal of cardiology, 184,

    133-140. https://doi.org/10.1016/j.amjcard.2022.08.025

    Visconti, L., Celi, A., Carrozzi, L., Tinelli, C., Crocetti, L., Daviddi, F., … &
    Pancani, R. (2024). Inferior vena cava filters: Concept review and
    summary of current guidelines. Vascular Pharmacology, 107375.
    https://doi.org/10.1016/j.vph.2024.107375

    Vrettou, C. S., Dima, E., & Sigala, I. (2024). Pulmonary Embolism in
    Critically Ill Patients— Prevention, Diagnosis, and Management.
    Diagnostics, 14(19), 2208.

    https://doi.org/10.3390/diagnostics14192208

    **## Extrainstruccionsforpresetation.docx**

    · When deciding on references, consider whether the
    **journal is high impact**. References should also be within the last 5 years.

    · References should be more related to practice guidelines and not clinical trials. We want to make sure that the presentation is clear on how to diagnose and treat PE related to current standards of practice. See below some links that may help.

    ·
    [https://pmc.ncbi.nlm.nih.gov/articles/PMC7284001/](https://pmc.ncbi.nlm.nih.gov/articles/PMC7284001/)

    ·
    [https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/treatment](https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/treatment)

    ·
    [https://www.ncbi.nlm.nih.gov/books/NBK560551/](https://www.ncbi.nlm.nih.gov/books/NBK560551/)

    ·
    [https://www.nejm.org/doi/full/10.1056/NEJMcp2116489](https://www.nejm.org/doi/full/10.1056/NEJMcp2116489)

    · Often times a hematologist will be consulted to see a patient with newly diagnosed DVT or PE. This would be a good source to reference from the American Society of Hematology.

    · Add 2 slides to the outline:

    · Comparison of prior standards for diagnosing and treating PEs. Remember our audience will be practitioners in practice with 20+ years and novice practitioners.

    · Populations for Special Considerations for treating PEs

    · What happens if a patient cannot be treated with Heparin, etc? The standard treatments.

    · Are there special considerations for cancer patients, older adults, etc.

    · Add treatment education for patients.

    **## RevisedOutline-PE.pdf**

    Slide 1: Title Slide
    A. Title: Diagnosis & Management of Pulmonary Embolism
    B. Presenter’s name and credentials
    C. Date and audience
    Slide 2: Introduction
    A. Purpose: Enhance NP skills in PE diagnosis and management
    B. Overview: Covers epidemiology, diagnosis, treatment, and NP role
    C. Importance: Improve patient outcomes in acute care
    Slide 3: Significance of PE
    A. Definition of pulmonary embolism
    B. Impact on morbidity and mortality
    C. Relevance to NP practice
    Slide 4: Epidemiology: Incidence
    A. Global and regional incidence rates
    B. Prevalence in acute care settings
    C. Public health implications
    Slide 5: Epidemiology: Demographics
    A. Age, gender, and ethnicity trends
    B. High-risk patient groups
    C. NP demographic awareness
    Slide 6: Risk Factors: Primary
    A. Immobility, surgery, and trauma
    B. Hospitalization-related risks
    C. NP risk screening techniques
    Slide 7: Risk Factors: Secondary
    A. Malignancy, pregnancy, and hormonal therapy
    B. Genetic and chronic conditions
    C. NP history-taking focus
    Slide 8: Pathophysiology: Thrombus Formation
    A. Process of clot development
    B. Link to venous thromboembolism
    C. Clinical relevance
    Slide 9: Pathophysiology: Systemic Impact
    A. Effects on pulmonary circulation
    B. Cardiac and hemodynamic consequences
    C. NP care implications
    Slide 10: Clinical Symptoms: Common
    A. Dyspnea, chest pain, tachycardia
    B. Hypoxia and respiratory distress
    C. NP symptom identification
    Slide 11: Clinical Symptoms: Atypical
    A. Syncope, fatigue, and vague symptoms

    B. Challenges in atypical cases
    C. NP vigilance
    Slide 12: Physical Assessment: Core Techniques
    A. Vital signs and oxygen saturation
    B. Respiratory system evaluation
    C. NP exam fundamentals
    Slide 13: Physical Assessment: Specialized Findings
    A. Cardiac signs and peripheral edema
    B. Lung auscultation specifics
    C. NP documentation skills
    Slide 14: Clinical Decision Tools: Wells Score
    A. Components and scoring
    B. Probability assessment
    C. NP application in practice
    Slide 15: Clinical Decision Tools: Geneva Score
    A. Revised Geneva Score overview
    B. Use in acute settings
    C. NP decision-making aid
    Slide 16: Laboratory Tests: D-dimer
    A. Role in ruling out PE
    B. Test limitations and specificity
    C. NP interpretation
    Slide 17: Laboratory Tests: Additional Markers
    A. Troponin, BNP, and ABG
    B. Supporting diagnostic process
    C. NP result integration
    Slide 18: Imaging: CT Pulmonary Angiography
    A. Gold standard for PE diagnosis
    B. Procedure and indications
    C. NP coordination role
    Slide 19: Imaging: V/Q Scan
    A. Alternative imaging option
    B. Indications and limitations
    C. NP imaging decisions
    Slide 20: Diagnostic Standards: New vs Old
    A. Discuss historical standard for imaging and PE diagnosis
    B. Discuss new gold-standard for imaging and PE diagnosis
    C. Discuss reasons for change in standard
    Slide 21: Diagnostic Workflow
    A. Stepwise PE diagnostic approach
    B. Combining clinical and test data
    C. NP efficiency in diagnosis

    Slide 22: Anticoagulation: First-Line Therapy
    A. Low-molecular-weight heparin, DOACs
    B. Dosing and administration
    C. NP treatment initiation
    Slide 23: Anticoagulation: Monitoring
    A. Bleeding risk and side effects
    B. Lab monitoring requirements
    C. NP patient oversight
    Slide 24: Thrombolytic Therapy
    A. Indications for high-risk PE
    B. Risks and contraindications
    C. NP role in critical care
    Slide 25: Non-Pharmacologic: Supportive Care
    A. Oxygen therapy and ventilation
    B. Hemodynamic stabilization
    C. NP care planning
    Slide 26: Non-Pharmacologic: IVC Filters
    A. Indications and procedure
    B. Follow-up and complications
    C. NP involvement
    Slide 27: Special Populations:
    A. Pregnancy & Postpartum
    B. Children & VTE
    Slide 28: Special Populations:
    A. Discuss clinical presentation, diagnostic workup, treatment
    B. Follow-up and long-term management
    Slide 29: Decision Tree for PE
    A. attach image of decision tree
    Slide 30: Patient Education: Treatment Adherence
    A. Importance of medication compliance
    B. Recognizing adverse effects
    C. NP education strategies
    Slide 31: Patient Education: Lifestyle Changes
    A. Activity, diet, and risk reduction
    B. Long-term health strategies
    C. NP counseling techniques
    Slide 32: Follow-Up Care
    A. Anticoagulation duration and monitoring
    B. Scheduling follow-up visits
    C. NP role in continuity

    Slide 33: Complications and Prevention
    A. Chronic thromboembolic disease, recurrence
    B. Thromboprophylaxis and risk stratification
    C. NP advocacy for prevention
    Slide 34: Conclusion and Q&A
    A. Summary of key points
    B. NP impact on PE outcomes
    C. Open floor for questions
    Slide 35: References
    Chopard, R., Behr, J., Vidoni, C., Ecarnot, F., & Meneveau, N. (2022).
    An update on the management of acute high-risk pulmonary
    embolism. Journal of Clinical Medicine, 11(16), 4807.
    https://doi.org/10.3390/jcm11164807

    de Wit, K., & D’Arsigny, C. L. (2023). Risk stratification of acute pulmonary
    embolism. Journal of Thrombosis and Haemostasis, 21(11),
    3016-3023.
    https://doi.org/10.1016/j.jtha.2023.05.003

    Duffy, J., Berger, F. H., Cheng, I., Shelton, D., Galanaud, J. P., Selby, R.,
    … & Hall, J. (2023). Implementation of the YEARS algorithm to
    optimise pulmonary embolism diagnostic workup in the emergency
    department. BMJ Open Quality, 12(2), e002119.
    https://bmjopenquality.bmj.com/content/12/2/e002119

    Højen, A. A., Nielsen, P. B., Overvad, T. F., Albertsen, I. E., Klok, F. A.,
    Rolving, N., … & Ording, A. G. (2022). Long-term management of
    pulmonary embolism: a review of consequences, treatment, and
    rehabilitation. Journal of Clinical Medicine, 11(19), 5970.

    https://doi.org/10.3390/jcm11195970

    Khan, F., Tritschler, T., Kahn, S. R., & Rodger, M. A. (2021). Venous
    thromboembolism. The lancet, 398(10294), 64-77.
    https://www.thelancet.com/article/S0140-6736(20)32658- 1/abstract

    Kulka, H. C., Zeller, A., Fornaro, J., Wuillemin, W. A., Konstantinides, S.,
    & Christ, M. (2021). Acute Pulmonary Embolism: its diagnosis and
    treatment from a multidisciplinary viewpoint. Deutsches Ärzteblatt
    international, 118(37), 618.
    https://doi.org/10.3238/arztebl.m2021.0226

    Monteleone, P., Ahern, R., Banerjee, S., Desai, K. R., Kadian-Dodov, D.,
    Webber, E., … & Parikh, S. A. (2024). Modern treatment of pulmonary
    embolism (USCDT vs MT): results from a real-world, big data
    analysis (REAL-PE). Journal of the Society for Cardiovascular
    Angiography & Interventions, 3(1), 101192.
    https://doi.org/10.1016/j.jscai.2023.101192

    Murthi, M., Velagapudi, S., Park, D. Y., & Shaka, H. (2022). Pulmonary
    embolism readmission trend over the years (from a National
    Readmission Database). The American journal of cardiology, 184,

    133-140. https://doi.org/10.1016/j.amjcard.2022.08.025

    Visconti, L., Celi, A., Carrozzi, L., Tinelli, C., Crocetti, L., Daviddi, F., … &
    Pancani, R. (2024). Inferior vena cava filters: Concept review and
    summary of current guidelines. Vascular Pharmacology, 107375.
    https://doi.org/10.1016/j.vph.2024.107375

    Vrettou, C. S., Dima, E., & Sigala, I. (2024). Pulmonary Embolism in
    Critically Ill Patients— Prevention, Diagnosis, and Management.
    Diagnostics, 14(19), 2208.

    https://doi.org/10.3390/diagnostics14192208

    – 1
    – 2

  • [Solved] WK 5 RESP

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    – ## WK5DIS.docx **## WK5DIS.docx** Data Science Applications and Processes ![A person standing in a hallway with a computer AI-generated content may be incorrect.](https://www.sweetstudy.com/questions/wk-5-resp-20924513) How might data compiled and analyzed in your healthcare organization or nursin…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    – ## WK5DIS.docx

    **## WK5DIS.docx**

    Data Science Applications and Processes

    ![A person standing in a hallway with a computer AI-generated content may be incorrect.](https://www.sweetstudy.com/questions/wk-5-resp-20924513)

    How might data compiled and analyzed in your healthcare organization or nursing practice help support efforts aimed at patient quality and safety? Why might it be important to consider the how’s and why’s of data collection, application, and implementation? How might these practices shape your nursing practice or even the future of nursing?

    For this Discussion, you will explore various topics related to data and consider the process and application of each. Reflect on the use of these applications, but also consider the implications of how these applications might shape the future of nursing and healthcare practice.

    Resources

    Be sure to review the Learning Resources before completing this activity.
    Click the weekly resources link to access the resources.

    [**WEEKLY RESOURCES**](https://waldenu.instructure.com/courses/175732/modules/items/6883357)

    earning Resources

    [Required Readings](https://waldenu.instructure.com/courses/175732/pages/week-5-learning-resources?module_item_id=6883357)

    · Sipes, C. (2025).
    _Project management for the advanced practice nurse_ (3rd ed.). Springer Publishing.

    · Chapter 4, “Planning: Project Management—Phase 2” (pp. 85–130)

    · American Nurses Association. (2015).
    [_Nursing informaticsLinks to an external site._](https://search.ebscohost.com/login.aspx?direct=true&db=nlebk&AN=1021761&site=eds-live&scope=site&authtype=shib&custid=s6527200) _: Scope and standards of practice_  (2nd ed.).

    · “Standard 3: Outcomes Identification” (p. 71)

    · “Standard 4: Planning” (p. 72)1

    · Brennan, P. F., & Bakken, S. (2015).
    [Nursing needs big data and big data needs nursingLinks to an external site.](https://search.proquest.com/scholarly-journals/nursing-needs-big-data/docview/1754567620/se-2?accountid=14872).
    _Journal of Nursing Scholarship, 47_ (5), 477–484. doi:10.1111/jnu.12159 National Institutes of Health, Office of Data Science Strategy. (2021).
    _Data science_ .

    · Carter-Templeton, H., Nicoll, L. H., Wrigley, J., & Wyatt, T. H. (2021).
    [Big data in nursing: A bibliometric analysisLinks to an external site.](https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=edselc&AN=edselc.2-52.0-85165359701&site=eds-live&scope=site&custid=s6527200).
    _Online Journal of Issues in Nursing_,
    _26_(3). https://doi.org/10.3912/OJIN.Vol26No03Man02

    · Elsaleh, T., Enshaeifar, S., Rezvani, R., Acton, S. T., Janeiko, V., & Bermudez-Edo, M. (2020).
    [IoT-stream: A lightweight ontology for internet of things data streams and its use with data analytics and event detection servicesLinks to an external site.](https://search.ebscohost.com/login.aspx?direct=true&db=edsdoj&AN=edsdoj.41223e5652334f4790d24c0a1f639098&site=eds-live&scope=site&authtype=shib&custid=s6527200).
    _Sensors, 20_ (4), 953. doi:10.3390/s20040953

    · Zhu, R., Han, S., Su, Y., Zhang, C., Yu, Q., & Duan, Z. (2019).
    [The application of big data and the development of nursing science: A discussion paperLinks to an external site.](https://www.sciencedirect.com/science/article/pii/S2352013218305507).
    _International Journal of Nursing Sciences, 6_ (2), 229–234. doi:10.1016/j.ijnss.2019.03.001

    [Required Media](https://waldenu.instructure.com/courses/175732/pages/week-5-learning-resources?module_item_id=6883357)

    · IDG TECHTalk. (2020, March 27).
    [_What is predictive analyticsLinks to an external site._](https://www.youtube.com/watch?v=cVibCHRSxB0) _? Transforming data into future insights_[Video]. YouTube. https://www.youtube.com/watch?v=cVibCHRSxB0

    · Simplilearn. (2019, December 10).
    [_Big data in 5 minutes_ Links to an external site.](https://www.youtube.com/watch?v=bAyrObl7TYE) | What is big data?| introduction to big data | big data explained | simplilearn [Video]. YouTube. https://www.youtube.com/watch?v=bAyrObl7TYE

    [Optional Resources](https://waldenu.instructure.com/courses/175732/pages/week-5-learning-resources?module_item_id=6883357)

    · Parikh, R. B., Gdowski, A., Patt, D. A., Hertler, A., Mermel, C., & Bekelman, J. E. (2019). Using big data and predictive analytics to determine patient risk in oncology.
    [_American Society of Clinical Oncology Educational BookLinks to an external site._](https://doi.org/10.1200/EDBK_238891) _, 39_ , e53–e58. doi:10.1200/EDBK_238891

    · Spachos, D., Siafis, S., Bamidis, P., Kouvelas, D., & Papazisis, G. (2020).
    [Combining big data search analytics and the FDA adverse event reporting system database to detect a potential safety signal of mirtazapine abuseLinks to an external site.](https://go.openathens.net/redirector/waldenu.edu?url=https://doi.org/10.1177%2F1460458219901232).
    _Health Informatics Journal, 26_ (3), 2265–2279. doi:10.1177/1460458219901232

    [Previous](https://waldenu.instructure.com/courses/175732/modules/items/6883348)

    [Next](https://waldenu.instructure.com/courses/175732/modules/items/6883360)

    To Prepare

    · Review the Learning Resources for this week related to the topics: Big Data, Data Science, Data Mining, Data Analytics, and Machine Learning.

    · Consider the process and application of each topic.

    · Reflect on how each topic relates to nursing practice.

    By Day 3 of Week 5

    **Post** a summary on how predictive analytics might be used to support healthcare.
    **Note:** These topics may overlap as you will find in the readings (e.g., some processes require both Data Mining and Analytics).

    In your post include the following:

    · Describe a practical application for predictive analytics in your nursing practice. What challenges and opportunities do you envision for the future of predictive analytics in healthcare?

    By Day 6 of Week 5

    **Read** a selection of your colleagues’ responses and
    **respond** to
    **at least two** of your colleagues on
    **two different days**. Expand upon your colleague’s posting or offer an alternative perspective.

    RESPOND TO THIS DISCUSSION POST

    Markesia

    Week 5 Main Response

    Predictive analytics and artificial intelligence have emerged as valuable tools to improve nursing science and patient outcomes. Big data systems can collectively gather data through machine learning and predictive analysis that tailors personalized care and better informs clinical decisions (Zhu et al., 2019). Nursing informatics applies technology to support disseminating evidence-based practices through education, support systems, and predictive analysis (American Nurses Association, 2015).  The American Nurses Association Standards of Professional Performance Standard 10 suggest using data to analyze outcomes, while monitoring the effectiveness of each action (American Nurses Association, 2015). This discussion will review the practical application of predictive analysis in the outpatient hemodialysis center.

    Data science and analytics require a collaborative approach from many disciplines, using theory, research, and a methodical approach to information discovery (Brennan & Bakken, 2015). Fresenius Medical Care’s outpatient dialysis centers developed a machine learning program incorporating cloud computing to send signals to the dialysis machine based on trends proactively. (Olasvrud, 2023). The process of ultrafiltration, or fluid removal, can result in severe intradialytic hypotension requiring emergency treatment. Prolonged hypotension is associated with decreased quality of life, excessive clotting of vascular access, and lower clinical effectiveness of treatments (Olasvrud, 2023).  As a Quality nurse in facilities, Quality Assessment and improvement programs demonstrate reduced hospitalizations and treatment complications, and improved outcomes throughout clinics nationwide through early interventions.

    The importance of big data and predictive analytics cannot be overstated in our healthcare system. Despite the improvement in outcomes, data privacy remains a concern. Outpatient dialysis clinics must use VPN and firewalls to maintain the integrity of information. As part of government standards, firewall and VPN protection are now required for many services. The Center for Medicare and Medicaid Services now provides the CMS online manual system, which provides direction for billing services (U.S. Centers for Medicare and Medicaid Services, 2024). Data analytics and mining could further inform nursing practice, decreasing mortality and improving overall outcomes.

    References

    American Nurses Association. (2015).
    _Nursing Informatics Scope and Standards of Practice_ (2nd ed.).
    [https://doi.org/Nursing Informatics Scope and Standards of PracticeLinks to an external site.](https://doi.org/Nursing%20Informatics%20Scope%20and%20Standards%20of%20Practice)

    Brennan, P. F., & Bakken, S. (2015). Nursing needs big data, and big data needs nursing.
    _Journal of Nursing Scholarship_,
    _47_(5), 477–484.
    [https://doi.org/10.1111/jnu.12159Links to an external site.](https://doi.org/10.1111/jnu.12159)

    Olasvrud, T. (2023, October 18).
    _Predictive analytics helps Fresenius Medical Care anticipate dialysis complications_. CIO.
    [https://www.cio.com/article/656024/predictive-analytics-helps-fresenius-anticipate-dialysis-complications.htmlLinks to an external site.](https://www.cio.com/article/656024/predictive-analytics-helps-fresenius-anticipate-dialysis-complications.html)

    U.S. Centers for Medicare and Medicaid Services. (2024, September 10).
    _Manuals_. CMS.gov.
    [https://www.cms.gov/medicare/regulations-guidance/manualsLinks to an external site.](https://www.cms.gov/medicare/regulations-guidance/manuals)

    Zhu, R., Han, S., Su, Y., Zhang, C., Yu, Q., & Duan, Z. (2019). The application of big data and the development of nursing science: A discussion paper.
    _International Journal of Nursing Sciences_,
    _6_(2), 229–234.
    [https://doi.org/10.1016/j.ijnss.2019.03.001Links to an external site.](https://doi.org/10.1016/j.ijnss.2019.03.001)

    ## image1.jpeg

    **## WK5DIS.docx**

    Data Science Applications and Processes

    ![A person standing in a hallway with a computer AI-generated content may be incorrect.](https://www.sweetstudy.com/questions/wk-5-resp-20924513)

    How might data compiled and analyzed in your healthcare organization or nursing practice help support efforts aimed at patient quality and safety? Why might it be important to consider the how’s and why’s of data collection, application, and implementation? How might these practices shape your nursing practice or even the future of nursing?

    For this Discussion, you will explore various topics related to data and consider the process and application of each. Reflect on the use of these applications, but also consider the implications of how these applications might shape the future of nursing and healthcare practice.

    Resources

    Be sure to review the Learning Resources before completing this activity.
    Click the weekly resources link to access the resources.

    [**WEEKLY RESOURCES**](https://waldenu.instructure.com/courses/175732/modules/items/6883357)

    earning Resources

    [Required Readings](https://waldenu.instructure.com/courses/175732/pages/week-5-learning-resources?module_item_id=6883357)

    · Sipes, C. (2025).
    _Project management for the advanced practice nurse_ (3rd ed.). Springer Publishing.

    · Chapter 4, “Planning: Project Management—Phase 2” (pp. 85–130)

    · American Nurses Association. (2015).
    [_Nursing informaticsLinks to an external site._](https://search.ebscohost.com/login.aspx?direct=true&db=nlebk&AN=1021761&site=eds-live&scope=site&authtype=shib&custid=s6527200) _: Scope and standards of practice_  (2nd ed.).

    · “Standard 3: Outcomes Identification” (p. 71)

    · “Standard 4: Planning” (p. 72)1

    · Brennan, P. F., & Bakken, S. (2015).
    [Nursing needs big data and big data needs nursingLinks to an external site.](https://search.proquest.com/scholarly-journals/nursing-needs-big-data/docview/1754567620/se-2?accountid=14872).
    _Journal of Nursing Scholarship, 47_ (5), 477–484. doi:10.1111/jnu.12159 National Institutes of Health, Office of Data Science Strategy. (2021).
    _Data science_ .

    · Carter-Templeton, H., Nicoll, L. H., Wrigley, J., & Wyatt, T. H. (2021).
    [Big data in nursing: A bibliometric analysisLinks to an external site.](https://search.ebscohost.com/login.aspx?direct=true&AuthType=shib&db=edselc&AN=edselc.2-52.0-85165359701&site=eds-live&scope=site&custid=s6527200).
    _Online Journal of Issues in Nursing_,
    _26_(3). https://doi.org/10.3912/OJIN.Vol26No03Man02

    · Elsaleh, T., Enshaeifar, S., Rezvani, R., Acton, S. T., Janeiko, V., & Bermudez-Edo, M. (2020).
    [IoT-stream: A lightweight ontology for internet of things data streams and its use with data analytics and event detection servicesLinks to an external site.](https://search.ebscohost.com/login.aspx?direct=true&db=edsdoj&AN=edsdoj.41223e5652334f4790d24c0a1f639098&site=eds-live&scope=site&authtype=shib&custid=s6527200).
    _Sensors, 20_ (4), 953. doi:10.3390/s20040953

    · Zhu, R., Han, S., Su, Y., Zhang, C., Yu, Q., & Duan, Z. (2019).
    [The application of big data and the development of nursing science: A discussion paperLinks to an external site.](https://www.sciencedirect.com/science/article/pii/S2352013218305507).
    _International Journal of Nursing Sciences, 6_ (2), 229–234. doi:10.1016/j.ijnss.2019.03.001

    [Required Media](https://waldenu.instructure.com/courses/175732/pages/week-5-learning-resources?module_item_id=6883357)

    · IDG TECHTalk. (2020, March 27).
    [_What is predictive analyticsLinks to an external site._](https://www.youtube.com/watch?v=cVibCHRSxB0) _? Transforming data into future insights_[Video]. YouTube. https://www.youtube.com/watch?v=cVibCHRSxB0

    · Simplilearn. (2019, December 10).
    [_Big data in 5 minutes_ Links to an external site.](https://www.youtube.com/watch?v=bAyrObl7TYE) | What is big data?| introduction to big data | big data explained | simplilearn [Video]. YouTube. https://www.youtube.com/watch?v=bAyrObl7TYE

    [Optional Resources](https://waldenu.instructure.com/courses/175732/pages/week-5-learning-resources?module_item_id=6883357)

    · Parikh, R. B., Gdowski, A., Patt, D. A., Hertler, A., Mermel, C., & Bekelman, J. E. (2019). Using big data and predictive analytics to determine patient risk in oncology.
    [_American Society of Clinical Oncology Educational BookLinks to an external site._](https://doi.org/10.1200/EDBK_238891) _, 39_ , e53–e58. doi:10.1200/EDBK_238891

    · Spachos, D., Siafis, S., Bamidis, P., Kouvelas, D., & Papazisis, G. (2020).
    [Combining big data search analytics and the FDA adverse event reporting system database to detect a potential safety signal of mirtazapine abuseLinks to an external site.](https://go.openathens.net/redirector/waldenu.edu?url=https://doi.org/10.1177%2F1460458219901232).
    _Health Informatics Journal, 26_ (3), 2265–2279. doi:10.1177/1460458219901232

    [Previous](https://waldenu.instructure.com/courses/175732/modules/items/6883348)

    [Next](https://waldenu.instructure.com/courses/175732/modules/items/6883360)

    To Prepare

    · Review the Learning Resources for this week related to the topics: Big Data, Data Science, Data Mining, Data Analytics, and Machine Learning.

    · Consider the process and application of each topic.

    · Reflect on how each topic relates to nursing practice.

    By Day 3 of Week 5

    **Post** a summary on how predictive analytics might be used to support healthcare.
    **Note:** These topics may overlap as you will find in the readings (e.g., some processes require both Data Mining and Analytics).

    In your post include the following:

    · Describe a practical application for predictive analytics in your nursing practice. What challenges and opportunities do you envision for the future of predictive analytics in healthcare?

    By Day 6 of Week 5

    **Read** a selection of your colleagues’ responses and
    **respond** to
    **at least two** of your colleagues on
    **two different days**. Expand upon your colleague’s posting or offer an alternative perspective.

    RESPOND TO THIS DISCUSSION POST

    Markesia

    Week 5 Main Response

    Predictive analytics and artificial intelligence have emerged as valuable tools to improve nursing science and patient outcomes. Big data systems can collectively gather data through machine learning and predictive analysis that tailors personalized care and better informs clinical decisions (Zhu et al., 2019). Nursing informatics applies technology to support disseminating evidence-based practices through education, support systems, and predictive analysis (American Nurses Association, 2015).  The American Nurses Association Standards of Professional Performance Standard 10 suggest using data to analyze outcomes, while monitoring the effectiveness of each action (American Nurses Association, 2015). This discussion will review the practical application of predictive analysis in the outpatient hemodialysis center.

    Data science and analytics require a collaborative approach from many disciplines, using theory, research, and a methodical approach to information discovery (Brennan & Bakken, 2015). Fresenius Medical Care’s outpatient dialysis centers developed a machine learning program incorporating cloud computing to send signals to the dialysis machine based on trends proactively. (Olasvrud, 2023). The process of ultrafiltration, or fluid removal, can result in severe intradialytic hypotension requiring emergency treatment. Prolonged hypotension is associated with decreased quality of life, excessive clotting of vascular access, and lower clinical effectiveness of treatments (Olasvrud, 2023).  As a Quality nurse in facilities, Quality Assessment and improvement programs demonstrate reduced hospitalizations and treatment complications, and improved outcomes throughout clinics nationwide through early interventions.

    The importance of big data and predictive analytics cannot be overstated in our healthcare system. Despite the improvement in outcomes, data privacy remains a concern. Outpatient dialysis clinics must use VPN and firewalls to maintain the integrity of information. As part of government standards, firewall and VPN protection are now required for many services. The Center for Medicare and Medicaid Services now provides the CMS online manual system, which provides direction for billing services (U.S. Centers for Medicare and Medicaid Services, 2024). Data analytics and mining could further inform nursing practice, decreasing mortality and improving overall outcomes.

    References

    American Nurses Association. (2015).
    _Nursing Informatics Scope and Standards of Practice_ (2nd ed.).
    [https://doi.org/Nursing Informatics Scope and Standards of PracticeLinks to an external site.](https://doi.org/Nursing%20Informatics%20Scope%20and%20Standards%20of%20Practice)

    Brennan, P. F., & Bakken, S. (2015). Nursing needs big data, and big data needs nursing.
    _Journal of Nursing Scholarship_,
    _47_(5), 477–484.
    [https://doi.org/10.1111/jnu.12159Links to an external site.](https://doi.org/10.1111/jnu.12159)

    Olasvrud, T. (2023, October 18).
    _Predictive analytics helps Fresenius Medical Care anticipate dialysis complications_. CIO.
    [https://www.cio.com/article/656024/predictive-analytics-helps-fresenius-anticipate-dialysis-complications.htmlLinks to an external site.](https://www.cio.com/article/656024/predictive-analytics-helps-fresenius-anticipate-dialysis-complications.html)

    U.S. Centers for Medicare and Medicaid Services. (2024, September 10).
    _Manuals_. CMS.gov.
    [https://www.cms.gov/medicare/regulations-guidance/manualsLinks to an external site.](https://www.cms.gov/medicare/regulations-guidance/manuals)

    Zhu, R., Han, S., Su, Y., Zhang, C., Yu, Q., & Duan, Z. (2019). The application of big data and the development of nursing science: A discussion paper.
    _International Journal of Nursing Sciences_,
    _6_(2), 229–234.
    [https://doi.org/10.1016/j.ijnss.2019.03.001Links to an external site.](https://doi.org/10.1016/j.ijnss.2019.03.001)

    ## image1.jpeg

  • [Solved] WK3 DISCUSSION HP-212

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    COMPLETE IN DETAIL 250 WORDS – ## WK3DISCUSSIONHP-212.odt – ## WK3DISCUSSIONINFOHP-212.odt **## WK3DISCUSSIONHP-212.odt** ## Thumbnails/thumbnail.png ##### "Unspecified” Codes The use of “unspecified” codes has been a common topic of discussion in the industry. There is a sense that unspecified code…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    COMPLETE IN DETAIL 250 WORDS

    – ## WK3DISCUSSIONHP-212.odt

    – ## WK3DISCUSSIONINFOHP-212.odt

    **## WK3DISCUSSIONHP-212.odt**

    ## Thumbnails/thumbnail.png

    ##### "Unspecified” Codes

    The use of “unspecified” codes has been a common topic of discussion in the industry. There is a sense that unspecified codes will
    [corrupt](https://www.merriam-webster.com/dictionary/corrupt) the reliability of the data we compiled based on these codes. There seems to be a consensus that the use of these codes is bad and should be avoided. Read the following article specifically addressing the issue of unspecified ICD-10 codes.
    [Article](https://thedo.osteopathic.org/2016/09/are-unspecified-icd-10-codes-setting-your-practice-up-for-a-titanic-scenario/). Another disadvantage of unspecified codes is that they fail to document a patient’s complexity." “Physicians, who use lots of unspecified codes might start hearing, “Why can’t you see 25 or 28 patients a day? Why not put in a mid-level clinician to do this work?” Dr. Mazzola noted. Unspecified codes do often represent a missed opportunity, Mendenez agreed: “Many physicians’ documentation supports a more specific code; they’re just not using it.

    ###### Implement the concept of unspecified codes when used in code selection.

    Include all the following aspects in the discussion:

    – After reading the attached article, do you agree with the author? Why or Why Not?

    – Support your agreement or disagreement by providing an article that shares an example of an unspecified ICD-10-CM code.

    – What are the more specific code(s) that should be used instead of the unspecified code in the article you attached?

    – Discuss with your peers why this would be a more related coding choice.

    250 words

    **## WK3DISCUSSIONINFOHP-212.odt**

    ## Pictures/100000000000012C000000FA51B86765.jpg

    ## Pictures/100000000000012C000000FAD1D7D2B1.jpg

    ###### MED 2016

    ## Are unspecified ICD-10 codes setting your practice up for a Titanic scenario?

    ### On Oct. 1, 2016, CMS will start denying claims that use unspecified ICD-10 codes. Here’s how to avoid the iceberg of revenue disruption.

    Monday

    [Laura Selby](https://thedo.osteopathic.org/author/lselby/)

    [Contact Laura](mailto:thedo@osteopathic.org?subject=Re:%20Are%20unspecified%20ICD-10%20codes%20setting%20your%20practice%20up%20for%20a%20Titanic%20scenario?)

    – Email

    LinkedIn

    Twitter

    Facebook

    ###### Topics

    [ICD-10](https://thedo.osteopathic.org/tag/icd-10/) [OMED 2016](https://thedo.osteopathic.org/tag/omed-2016/)

    When the ICD-10 code set went into effect last Oct. 1, the Centers for Medicare and Medicaid Services (CMS) gave doctors a grace period of sorts: CMS wouldn’t deny claims for lack of specificity until Oct. 1, 2016. Given ICD-10’s total of 68,000 diagnostic codes, that was welcome news at the time, but Matthew Menendez says it may have lulled physicians into a false sense of security.

    “Delaying the denial of unspecified codes has enabled poor workflows to be successful,” said Menendez, the vice president of practice management company White Plume Technologies. “This is the part of the iceberg that’s below the water—it seems like it’s not a problem, but it’s out there waiting for us.”

    Menendez and family medicine physician Joseph Mazzola, DO, shared tips on what physicians can do to minimize claim denials as part of the American College of Osteopathic Family Physicians’ OMED 2016 program on Monday. Physicians who continue using unspecified codes after Oct. 1, 2016, risk denied claims and disruptions to their practice revenue cycles.

    The issue is especially relevant to physicians whose payment depends on the revenue they generate, Dr. Mazzola pointed out. “As denials come in, if you’re up for contract renewal, I may have to say, ‘Doctor, you’re doing fine with visit numbers, but your revenue is down,'” said Dr. Mazzola, who oversees more than 100 physicians in his role as chief medical officer for Blue Ridge HealthCare in Morganton, North Carolina.

    Another disadvantage of unspecified codes is that they fail to document patients’ complexity. “Physicians who use lots of unspecified codes might start hearing, ‘Why can’t you see 25 or 28 patients a day? Why not put in a midlevel clinician to do this work?'” Dr. Mazzola noted. Unspecified codes do often represent a missed opportunity, Menendez agreed: “Many physicians’ documentation supports a more specific code; they’re just not using it.”

    ### How to get started

    Although physicians should work to reduce unspecified codes, Menendez noted, the goal is not to eliminate them altogether. “You’re not aiming to get your unspecified codes down to zero—there are times using them is absolutely appropriate, such as when you’re waiting for lab results or it’s not clear what’s causing a patient’s fever,” he explained.

    To reduce use of unspecified codes, Dr. Mazzola and Menendez recommend these steps:

    – Analyze claims from the last six months to find out what percentage use unspecified codes.

    – Pinpoint the top 10 or 15 unspecified codes that appear most frequently in your claims.

    – Find more specific alternatives for your top unspecified codes. For example, there are six ICD-10 codes for hyperlipidemia that could be used in place of code E78.5—Hyperlipidemia, unspecified.

    Although the process might sound daunting, physicians can make a significant impact by focusing first on their most frequently used unspecified codes. “Your practice’s risk come October 1 really depends on how much specificity you’re coding with today and how much you’re willing to improve,” Menendez said. “It can be challenging to find a balance between using more specific codes without crushing physician productivity, but getting the right code the first time you submit a claim will really improve revenue efficiency.”

    [![](https://www.sweetstudy.com/questions/wk3-discussion-hp-212)](https://servedbyadbutler.com/redirect.spark?MID=165731&plid=3069835&setID=431039&channelID=0&CID=0&banID=523315830&PID=0&textadID=0&tc=1&rnd=9369742&scheduleID=3022629&adSize=300×250&mt=1750947634041093&sw=1440&sh=900&spr=2&referrer=https%3A%2F%2Fthedo.osteopathic.org%2F2016%2F09%2Fare-unspecified-icd-10-codes-setting-your-practice-up-for-a-titanic-scenario%2F&hc=2d6380ff8eb3f77e73abafd47184fa06f495c6b0&location=)

    [![](https://www.sweetstudy.com/questions/wk3-discussion-hp-212)](https://servedbyadbutler.com/redirect.spark?MID=165731&plid=3070070&setID=431040&channelID=0&CID=0&banID=523317602&PID=0&textadID=0&tc=1&rnd=9369742&scheduleID=3022864&adSize=300×250&mt=1750947634039027&sw=1440&sh=900&spr=2&referrer=https%3A%2F%2Fthedo.osteopathic.org%2F2016%2F09%2Fare-unspecified-icd-10-codes-setting-your-practice-up-for-a-titanic-scenario%2F&hc=b3980a130611acc1e82c54bdfc93007a499fda77&location=)

    #### Popular

    – – ###### [A life in medicine](https://thedo.osteopathic.org/2025/06/in-memoriam-june-2025/)

    #### [In Memoriam: June 2025](https://thedo.osteopathic.org/2025/06/in-memoriam-june-2025/)

    – ###### [Match 2026](https://thedo.osteopathic.org/2025/06/the-nrmp-2026-match-and-eras-timeline-for-residency-applicants/)

    #### [The NRMP 2026 Match and ERAS timeline for residency applicants](https://thedo.osteopathic.org/2025/06/the-nrmp-2026-match-and-eras-timeline-for-residency-applicants/)

    – ###### [Leadership](https://thedo.osteopathic.org/2025/06/as-cmo-for-the-us-department-of-energy-this-do-is-strengthening-worker-health/)

    #### [As CMO for the US Department of Energy, this DO is strengthening worker health](https://thedo.osteopathic.org/2025/06/as-cmo-for-the-us-department-of-energy-this-do-is-strengthening-worker-health/)

    – ###### [History](https://thedo.osteopathic.org/2025/06/learn-more-about-the-involvement-of-a-t-still-md-do-in-the-abolitionist-movement-in-kansas/)

    #### [Learn more about the involvement of A.T. Still, MD, DO, in the abolitionist movement in Kansas](https://thedo.osteopathic.org/2025/06/learn-more-about-the-involvement-of-a-t-still-md-do-in-the-abolitionist-movement-in-kansas/)

    – ###### [GME pearls](https://thedo.osteopathic.org/columns/top-10-dos-and-donts-in-residency/)

    #### [Top 10 Do’s and Don’ts in residency](https://thedo.osteopathic.org/columns/top-10-dos-and-donts-in-residency/)

    ## Thumbnails/thumbnail.png

    **## WK3DISCUSSIONINFOHP-212.odt**

    ## Pictures/100000000000012C000000FA51B86765.jpg

    ## Pictures/100000000000012C000000FAD1D7D2B1.jpg

    ###### MED 2016

    ## Are unspecified ICD-10 codes setting your practice up for a Titanic scenario?

    ### On Oct. 1, 2016, CMS will start denying claims that use unspecified ICD-10 codes. Here’s how to avoid the iceberg of revenue disruption.

    Monday

    [Laura Selby](https://thedo.osteopathic.org/author/lselby/)

    [Contact Laura](mailto:thedo@osteopathic.org?subject=Re:%20Are%20unspecified%20ICD-10%20codes%20setting%20your%20practice%20up%20for%20a%20Titanic%20scenario?)

    – Email

    LinkedIn

    Twitter

    Facebook

    ###### Topics

    [ICD-10](https://thedo.osteopathic.org/tag/icd-10/) [OMED 2016](https://thedo.osteopathic.org/tag/omed-2016/)

    When the ICD-10 code set went into effect last Oct. 1, the Centers for Medicare and Medicaid Services (CMS) gave doctors a grace period of sorts: CMS wouldn’t deny claims for lack of specificity until Oct. 1, 2016. Given ICD-10’s total of 68,000 diagnostic codes, that was welcome news at the time, but Matthew Menendez says it may have lulled physicians into a false sense of security.

    “Delaying the denial of unspecified codes has enabled poor workflows to be successful,” said Menendez, the vice president of practice management company White Plume Technologies. “This is the part of the iceberg that’s below the water—it seems like it’s not a problem, but it’s out there waiting for us.”

    Menendez and family medicine physician Joseph Mazzola, DO, shared tips on what physicians can do to minimize claim denials as part of the American College of Osteopathic Family Physicians’ OMED 2016 program on Monday. Physicians who continue using unspecified codes after Oct. 1, 2016, risk denied claims and disruptions to their practice revenue cycles.

    The issue is especially relevant to physicians whose payment depends on the revenue they generate, Dr. Mazzola pointed out. “As denials come in, if you’re up for contract renewal, I may have to say, ‘Doctor, you’re doing fine with visit numbers, but your revenue is down,'” said Dr. Mazzola, who oversees more than 100 physicians in his role as chief medical officer for Blue Ridge HealthCare in Morganton, North Carolina.

    Another disadvantage of unspecified codes is that they fail to document patients’ complexity. “Physicians who use lots of unspecified codes might start hearing, ‘Why can’t you see 25 or 28 patients a day? Why not put in a midlevel clinician to do this work?'” Dr. Mazzola noted. Unspecified codes do often represent a missed opportunity, Menendez agreed: “Many physicians’ documentation supports a more specific code; they’re just not using it.”

    ### How to get started

    Although physicians should work to reduce unspecified codes, Menendez noted, the goal is not to eliminate them altogether. “You’re not aiming to get your unspecified codes down to zero—there are times using them is absolutely appropriate, such as when you’re waiting for lab results or it’s not clear what’s causing a patient’s fever,” he explained.

    To reduce use of unspecified codes, Dr. Mazzola and Menendez recommend these steps:

    – Analyze claims from the last six months to find out what percentage use unspecified codes.

    – Pinpoint the top 10 or 15 unspecified codes that appear most frequently in your claims.

    – Find more specific alternatives for your top unspecified codes. For example, there are six ICD-10 codes for hyperlipidemia that could be used in place of code E78.5—Hyperlipidemia, unspecified.

    Although the process might sound daunting, physicians can make a significant impact by focusing first on their most frequently used unspecified codes. “Your practice’s risk come October 1 really depends on how much specificity you’re coding with today and how much you’re willing to improve,” Menendez said. “It can be challenging to find a balance between using more specific codes without crushing physician productivity, but getting the right code the first time you submit a claim will really improve revenue efficiency.”

    [![](https://www.sweetstudy.com/questions/wk3-discussion-hp-212)](https://servedbyadbutler.com/redirect.spark?MID=165731&plid=3069835&setID=431039&channelID=0&CID=0&banID=523315830&PID=0&textadID=0&tc=1&rnd=9369742&scheduleID=3022629&adSize=300×250&mt=1750947634041093&sw=1440&sh=900&spr=2&referrer=https%3A%2F%2Fthedo.osteopathic.org%2F2016%2F09%2Fare-unspecified-icd-10-codes-setting-your-practice-up-for-a-titanic-scenario%2F&hc=2d6380ff8eb3f77e73abafd47184fa06f495c6b0&location=)

    [![](https://www.sweetstudy.com/questions/wk3-discussion-hp-212)](https://servedbyadbutler.com/redirect.spark?MID=165731&plid=3070070&setID=431040&channelID=0&CID=0&banID=523317602&PID=0&textadID=0&tc=1&rnd=9369742&scheduleID=3022864&adSize=300×250&mt=1750947634039027&sw=1440&sh=900&spr=2&referrer=https%3A%2F%2Fthedo.osteopathic.org%2F2016%2F09%2Fare-unspecified-icd-10-codes-setting-your-practice-up-for-a-titanic-scenario%2F&hc=b3980a130611acc1e82c54bdfc93007a499fda77&location=)

    #### Popular

    – – ###### [A life in medicine](https://thedo.osteopathic.org/2025/06/in-memoriam-june-2025/)

    #### [In Memoriam: June 2025](https://thedo.osteopathic.org/2025/06/in-memoriam-june-2025/)

    – ###### [Match 2026](https://thedo.osteopathic.org/2025/06/the-nrmp-2026-match-and-eras-timeline-for-residency-applicants/)

    #### [The NRMP 2026 Match and ERAS timeline for residency applicants](https://thedo.osteopathic.org/2025/06/the-nrmp-2026-match-and-eras-timeline-for-residency-applicants/)

    – ###### [Leadership](https://thedo.osteopathic.org/2025/06/as-cmo-for-the-us-department-of-energy-this-do-is-strengthening-worker-health/)

    #### [As CMO for the US Department of Energy, this DO is strengthening worker health](https://thedo.osteopathic.org/2025/06/as-cmo-for-the-us-department-of-energy-this-do-is-strengthening-worker-health/)

    – ###### [History](https://thedo.osteopathic.org/2025/06/learn-more-about-the-involvement-of-a-t-still-md-do-in-the-abolitionist-movement-in-kansas/)

    #### [Learn more about the involvement of A.T. Still, MD, DO, in the abolitionist movement in Kansas](https://thedo.osteopathic.org/2025/06/learn-more-about-the-involvement-of-a-t-still-md-do-in-the-abolitionist-movement-in-kansas/)

    – ###### [GME pearls](https://thedo.osteopathic.org/columns/top-10-dos-and-donts-in-residency/)

    #### [Top 10 Do’s and Don’ts in residency](https://thedo.osteopathic.org/columns/top-10-dos-and-donts-in-residency/)

    ## Thumbnails/thumbnail.png

    **## WK3DISCUSSIONHP-212.odt**

    ## Thumbnails/thumbnail.png

    ##### "Unspecified” Codes

    The use of “unspecified” codes has been a common topic of discussion in the industry. There is a sense that unspecified codes will
    [corrupt](https://www.merriam-webster.com/dictionary/corrupt) the reliability of the data we compiled based on these codes. There seems to be a consensus that the use of these codes is bad and should be avoided. Read the following article specifically addressing the issue of unspecified ICD-10 codes.
    [Article](https://thedo.osteopathic.org/2016/09/are-unspecified-icd-10-codes-setting-your-practice-up-for-a-titanic-scenario/). Another disadvantage of unspecified codes is that they fail to document a patient’s complexity." “Physicians, who use lots of unspecified codes might start hearing, “Why can’t you see 25 or 28 patients a day? Why not put in a mid-level clinician to do this work?” Dr. Mazzola noted. Unspecified codes do often represent a missed opportunity, Mendenez agreed: “Many physicians’ documentation supports a more specific code; they’re just not using it.

    ###### Implement the concept of unspecified codes when used in code selection.

    Include all the following aspects in the discussion:

    – After reading the attached article, do you agree with the author? Why or Why Not?

    – Support your agreement or disagreement by providing an article that shares an example of an unspecified ICD-10-CM code.

    – What are the more specific code(s) that should be used instead of the unspecified code in the article you attached?

    – Discuss with your peers why this would be a more related coding choice.

    250 words

    **## WK3DISCUSSIONINFOHP-212.odt**

    ## Pictures/100000000000012C000000FA51B86765.jpg

    ## Pictures/100000000000012C000000FAD1D7D2B1.jpg

    ###### MED 2016

    ## Are unspecified ICD-10 codes setting your practice up for a Titanic scenario?

    ### On Oct. 1, 2016, CMS will start denying claims that use unspecified ICD-10 codes. Here’s how to avoid the iceberg of revenue disruption.

    Monday

    [Laura Selby](https://thedo.osteopathic.org/author/lselby/)

    [Contact Laura](mailto:thedo@osteopathic.org?subject=Re:%20Are%20unspecified%20ICD-10%20codes%20setting%20your%20practice%20up%20for%20a%20Titanic%20scenario?)

    – Email

    LinkedIn

    Twitter

    Facebook

    ###### Topics

    [ICD-10](https://thedo.osteopathic.org/tag/icd-10/) [OMED 2016](https://thedo.osteopathic.org/tag/omed-2016/)

    When the ICD-10 code set went into effect last Oct. 1, the Centers for Medicare and Medicaid Services (CMS) gave doctors a grace period of sorts: CMS wouldn’t deny claims for lack of specificity until Oct. 1, 2016. Given ICD-10’s total of 68,000 diagnostic codes, that was welcome news at the time, but Matthew Menendez says it may have lulled physicians into a false sense of security.

    “Delaying the denial of unspecified codes has enabled poor workflows to be successful,” said Menendez, the vice president of practice management company White Plume Technologies. “This is the part of the iceberg that’s below the water—it seems like it’s not a problem, but it’s out there waiting for us.”

    Menendez and family medicine physician Joseph Mazzola, DO, shared tips on what physicians can do to minimize claim denials as part of the American College of Osteopathic Family Physicians’ OMED 2016 program on Monday. Physicians who continue using unspecified codes after Oct. 1, 2016, risk denied claims and disruptions to their practice revenue cycles.

    The issue is especially relevant to physicians whose payment depends on the revenue they generate, Dr. Mazzola pointed out. “As denials come in, if you’re up for contract renewal, I may have to say, ‘Doctor, you’re doing fine with visit numbers, but your revenue is down,'” said Dr. Mazzola, who oversees more than 100 physicians in his role as chief medical officer for Blue Ridge HealthCare in Morganton, North Carolina.

    Another disadvantage of unspecified codes is that they fail to document patients’ complexity. “Physicians who use lots of unspecified codes might start hearing, ‘Why can’t you see 25 or 28 patients a day? Why not put in a midlevel clinician to do this work?'” Dr. Mazzola noted. Unspecified codes do often represent a missed opportunity, Menendez agreed: “Many physicians’ documentation supports a more specific code; they’re just not using it.”

    ### How to get started

    Although physicians should work to reduce unspecified codes, Menendez noted, the goal is not to eliminate them altogether. “You’re not aiming to get your unspecified codes down to zero—there are times using them is absolutely appropriate, such as when you’re waiting for lab results or it’s not clear what’s causing a patient’s fever,” he explained.

    To reduce use of unspecified codes, Dr. Mazzola and Menendez recommend these steps:

    – Analyze claims from the last six months to find out what percentage use unspecified codes.

    – Pinpoint the top 10 or 15 unspecified codes that appear most frequently in your claims.

    – Find more specific alternatives for your top unspecified codes. For example, there are six ICD-10 codes for hyperlipidemia that could be used in place of code E78.5—Hyperlipidemia, unspecified.

    Although the process might sound daunting, physicians can make a significant impact by focusing first on their most frequently used unspecified codes. “Your practice’s risk come October 1 really depends on how much specificity you’re coding with today and how much you’re willing to improve,” Menendez said. “It can be challenging to find a balance between using more specific codes without crushing physician productivity, but getting the right code the first time you submit a claim will really improve revenue efficiency.”

    [![](https://www.sweetstudy.com/questions/wk3-discussion-hp-212)](https://servedbyadbutler.com/redirect.spark?MID=165731&plid=3069835&setID=431039&channelID=0&CID=0&banID=523315830&PID=0&textadID=0&tc=1&rnd=9369742&scheduleID=3022629&adSize=300×250&mt=1750947634041093&sw=1440&sh=900&spr=2&referrer=https%3A%2F%2Fthedo.osteopathic.org%2F2016%2F09%2Fare-unspecified-icd-10-codes-setting-your-practice-up-for-a-titanic-scenario%2F&hc=2d6380ff8eb3f77e73abafd47184fa06f495c6b0&location=)

    [![](https://www.sweetstudy.com/questions/wk3-discussion-hp-212)](https://servedbyadbutler.com/redirect.spark?MID=165731&plid=3070070&setID=431040&channelID=0&CID=0&banID=523317602&PID=0&textadID=0&tc=1&rnd=9369742&scheduleID=3022864&adSize=300×250&mt=1750947634039027&sw=1440&sh=900&spr=2&referrer=https%3A%2F%2Fthedo.osteopathic.org%2F2016%2F09%2Fare-unspecified-icd-10-codes-setting-your-practice-up-for-a-titanic-scenario%2F&hc=b3980a130611acc1e82c54bdfc93007a499fda77&location=)

    #### Popular

    – – ###### [A life in medicine](https://thedo.osteopathic.org/2025/06/in-memoriam-june-2025/)

    #### [In Memoriam: June 2025](https://thedo.osteopathic.org/2025/06/in-memoriam-june-2025/)

    – ###### [Match 2026](https://thedo.osteopathic.org/2025/06/the-nrmp-2026-match-and-eras-timeline-for-residency-applicants/)

    #### [The NRMP 2026 Match and ERAS timeline for residency applicants](https://thedo.osteopathic.org/2025/06/the-nrmp-2026-match-and-eras-timeline-for-residency-applicants/)

    – ###### [Leadership](https://thedo.osteopathic.org/2025/06/as-cmo-for-the-us-department-of-energy-this-do-is-strengthening-worker-health/)

    #### [As CMO for the US Department of Energy, this DO is strengthening worker health](https://thedo.osteopathic.org/2025/06/as-cmo-for-the-us-department-of-energy-this-do-is-strengthening-worker-health/)

    – ###### [History](https://thedo.osteopathic.org/2025/06/learn-more-about-the-involvement-of-a-t-still-md-do-in-the-abolitionist-movement-in-kansas/)

    #### [Learn more about the involvement of A.T. Still, MD, DO, in the abolitionist movement in Kansas](https://thedo.osteopathic.org/2025/06/learn-more-about-the-involvement-of-a-t-still-md-do-in-the-abolitionist-movement-in-kansas/)

    – ###### [GME pearls](https://thedo.osteopathic.org/columns/top-10-dos-and-donts-in-residency/)

    #### [Top 10 Do’s and Don’ts in residency](https://thedo.osteopathic.org/columns/top-10-dos-and-donts-in-residency/)

    ## Thumbnails/thumbnail.png

    **## WK3DISCUSSIONHP-212.odt**

    ## Thumbnails/thumbnail.png

    ##### "Unspecified” Codes

    The use of “unspecified” codes has been a common topic of discussion in the industry. There is a sense that unspecified codes will
    [corrupt](https://www.merriam-webster.com/dictionary/corrupt) the reliability of the data we compiled based on these codes. There seems to be a consensus that the use of these codes is bad and should be avoided. Read the following article specifically addressing the issue of unspecified ICD-10 codes.
    [Article](https://thedo.osteopathic.org/2016/09/are-unspecified-icd-10-codes-setting-your-practice-up-for-a-titanic-scenario/). Another disadvantage of unspecified codes is that they fail to document a patient’s complexity." “Physicians, who use lots of unspecified codes might start hearing, “Why can’t you see 25 or 28 patients a day? Why not put in a mid-level clinician to do this work?” Dr. Mazzola noted. Unspecified codes do often represent a missed opportunity, Mendenez agreed: “Many physicians’ documentation supports a more specific code; they’re just not using it.

    ###### Implement the concept of unspecified codes when used in code selection.

    Include all the following aspects in the discussion:

    – After reading the attached article, do you agree with the author? Why or Why Not?

    – Support your agreement or disagreement by providing an article that shares an example of an unspecified ICD-10-CM code.

    – What are the more specific code(s) that should be used instead of the unspecified code in the article you attached?

    – Discuss with your peers why this would be a more related coding choice.

    250 words

    **## WK3DISCUSSIONINFOHP-212.odt**

    ## Pictures/100000000000012C000000FA51B86765.jpg

    ## Pictures/100000000000012C000000FAD1D7D2B1.jpg

    ###### MED 2016

    ## Are unspecified ICD-10 codes setting your practice up for a Titanic scenario?

    ### On Oct. 1, 2016, CMS will start denying claims that use unspecified ICD-10 codes. Here’s how to avoid the iceberg of revenue disruption.

    Monday

    [Laura Selby](https://thedo.osteopathic.org/author/lselby/)

    [Contact Laura](mailto:thedo@osteopathic.org?subject=Re:%20Are%20unspecified%20ICD-10%20codes%20setting%20your%20practice%20up%20for%20a%20Titanic%20scenario?)

    – Email

    LinkedIn

    Twitter

    Facebook

    ###### Topics

    [ICD-10](https://thedo.osteopathic.org/tag/icd-10/) [OMED 2016](https://thedo.osteopathic.org/tag/omed-2016/)

    When the ICD-10 code set went into effect last Oct. 1, the Centers for Medicare and Medicaid Services (CMS) gave doctors a grace period of sorts: CMS wouldn’t deny claims for lack of specificity until Oct. 1, 2016. Given ICD-10’s total of 68,000 diagnostic codes, that was welcome news at the time, but Matthew Menendez says it may have lulled physicians into a false sense of security.

    “Delaying the denial of unspecified codes has enabled poor workflows to be successful,” said Menendez, the vice president of practice management company White Plume Technologies. “This is the part of the iceberg that’s below the water—it seems like it’s not a problem, but it’s out there waiting for us.”

    Menendez and family medicine physician Joseph Mazzola, DO, shared tips on what physicians can do to minimize claim denials as part of the American College of Osteopathic Family Physicians’ OMED 2016 program on Monday. Physicians who continue using unspecified codes after Oct. 1, 2016, risk denied claims and disruptions to their practice revenue cycles.

    The issue is especially relevant to physicians whose payment depends on the revenue they generate, Dr. Mazzola pointed out. “As denials come in, if you’re up for contract renewal, I may have to say, ‘Doctor, you’re doing fine with visit numbers, but your revenue is down,'” said Dr. Mazzola, who oversees more than 100 physicians in his role as chief medical officer for Blue Ridge HealthCare in Morganton, North Carolina.

    Another disadvantage of unspecified codes is that they fail to document patients’ complexity. “Physicians who use lots of unspecified codes might start hearing, ‘Why can’t you see 25 or 28 patients a day? Why not put in a midlevel clinician to do this work?'” Dr. Mazzola noted. Unspecified codes do often represent a missed opportunity, Menendez agreed: “Many physicians’ documentation supports a more specific code; they’re just not using it.”

    ### How to get started

    Although physicians should work to reduce unspecified codes, Menendez noted, the goal is not to eliminate them altogether. “You’re not aiming to get your unspecified codes down to zero—there are times using them is absolutely appropriate, such as when you’re waiting for lab results or it’s not clear what’s causing a patient’s fever,” he explained.

    To reduce use of unspecified codes, Dr. Mazzola and Menendez recommend these steps:

    – Analyze claims from the last six months to find out what percentage use unspecified codes.

    – Pinpoint the top 10 or 15 unspecified codes that appear most frequently in your claims.

    – Find more specific alternatives for your top unspecified codes. For example, there are six ICD-10 codes for hyperlipidemia that could be used in place of code E78.5—Hyperlipidemia, unspecified.

    Although the process might sound daunting, physicians can make a significant impact by focusing first on their most frequently used unspecified codes. “Your practice’s risk come October 1 really depends on how much specificity you’re coding with today and how much you’re willing to improve,” Menendez said. “It can be challenging to find a balance between using more specific codes without crushing physician productivity, but getting the right code the first time you submit a claim will really improve revenue efficiency.”

    [![](https://www.sweetstudy.com/questions/wk3-discussion-hp-212)](https://servedbyadbutler.com/redirect.spark?MID=165731&plid=3069835&setID=431039&channelID=0&CID=0&banID=523315830&PID=0&textadID=0&tc=1&rnd=9369742&scheduleID=3022629&adSize=300×250&mt=1750947634041093&sw=1440&sh=900&spr=2&referrer=https%3A%2F%2Fthedo.osteopathic.org%2F2016%2F09%2Fare-unspecified-icd-10-codes-setting-your-practice-up-for-a-titanic-scenario%2F&hc=2d6380ff8eb3f77e73abafd47184fa06f495c6b0&location=)

    [![](https://www.sweetstudy.com/questions/wk3-discussion-hp-212)](https://servedbyadbutler.com/redirect.spark?MID=165731&plid=3070070&setID=431040&channelID=0&CID=0&banID=523317602&PID=0&textadID=0&tc=1&rnd=9369742&scheduleID=3022864&adSize=300×250&mt=1750947634039027&sw=1440&sh=900&spr=2&referrer=https%3A%2F%2Fthedo.osteopathic.org%2F2016%2F09%2Fare-unspecified-icd-10-codes-setting-your-practice-up-for-a-titanic-scenario%2F&hc=b3980a130611acc1e82c54bdfc93007a499fda77&location=)

    #### Popular

    – – ###### [A life in medicine](https://thedo.osteopathic.org/2025/06/in-memoriam-june-2025/)

    #### [In Memoriam: June 2025](https://thedo.osteopathic.org/2025/06/in-memoriam-june-2025/)

    – ###### [Match 2026](https://thedo.osteopathic.org/2025/06/the-nrmp-2026-match-and-eras-timeline-for-residency-applicants/)

    #### [The NRMP 2026 Match and ERAS timeline for residency applicants](https://thedo.osteopathic.org/2025/06/the-nrmp-2026-match-and-eras-timeline-for-residency-applicants/)

    – ###### [Leadership](https://thedo.osteopathic.org/2025/06/as-cmo-for-the-us-department-of-energy-this-do-is-strengthening-worker-health/)

    #### [As CMO for the US Department of Energy, this DO is strengthening worker health](https://thedo.osteopathic.org/2025/06/as-cmo-for-the-us-department-of-energy-this-do-is-strengthening-worker-health/)

    – ###### [History](https://thedo.osteopathic.org/2025/06/learn-more-about-the-involvement-of-a-t-still-md-do-in-the-abolitionist-movement-in-kansas/)

    #### [Learn more about the involvement of A.T. Still, MD, DO, in the abolitionist movement in Kansas](https://thedo.osteopathic.org/2025/06/learn-more-about-the-involvement-of-a-t-still-md-do-in-the-abolitionist-movement-in-kansas/)

    – ###### [GME pearls](https://thedo.osteopathic.org/columns/top-10-dos-and-donts-in-residency/)

    #### [Top 10 Do’s and Don’ts in residency](https://thedo.osteopathic.org/columns/top-10-dos-and-donts-in-residency/)

    ## Thumbnails/thumbnail.png

    – 1
    – 2

  • [Solved] WK3 QUESTIONS HP-212

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    COMPLETE ALL QUESTIONS – ## WK3QUESTIONSHP-212.odt **## WK3QUESTIONSHP-212.odt** ## Thumbnails/thumbnail.png 1) To initially locate an ICD-10-CM external causes code, go to the Responses – Index to External Cause of Injuries. – Index to Diseases and Injuries. – Index to Procedures. – Table of Drugs …

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    COMPLETE ALL QUESTIONS

    – ## WK3QUESTIONSHP-212.odt

    **## WK3QUESTIONSHP-212.odt**

    ## Thumbnails/thumbnail.png

    1) To initially locate an ICD-10-CM external causes code, go to the

    Responses

    – Index to External Cause of Injuries.

    – Index to Diseases and Injuries.

    – Index to Procedures.

    – Table of Drugs and Chemicals.

    2) Persons with unavailability and inaccessibility of health care facilities" is an example of a(n)

    Responses

    – separate index in the ICD-10-CM coding manual.

    – section in the HCPCS level II coding system.

    – chapter of Z codes in ICD-10-CM.

    – ICD-10-CM grouping of external causes codes.

    3) Which set of codes is used to report how an injury or condition happened, the intent, the place of occurrence, the activity of the patient at the time of the event, and the person's status?

    Responses

    – ICD-10-CM signs and symptoms codes

    – ICD-10-CM Z codes

    – ICD-10-CM external causes codes

    – A separate index in ICD-10-CM

    4) The ICD-10-CM Tabular List of Diseases and Injuries is referenced

    Responses

    – if the phrase "omit code" is included in the index.

    – for verification of external causes codes only.

    – when a procedure code is listed as unspecified.

    – to verify codes selected and to review instructions.

    5) The patient is treated for diabetes mellitus controlled by medication, and during the same encounter, he tells the physician that he has been experiencing severe indigestion. The physician discussed possible reasons for indigestion with the patient, who admitted to having eaten a lot of spicy foods in the past month. The patient is unwilling to take over-the-counter or prescription medications for the indigestion, and the physician suggested alternative solutions. The physician also instructed the patient to return in two weeks for follow-up of the indigestion. To completely code this case, assign ICD-10-CM code(s) for

    Responses

    – diabetes mellitus, indigestion.

    – diabetes mellitus.

    – indigestion.

    – diabetes mellitus, chest pain.

    6) Which type of note is usually found below the infectious disease code in the ICD-10-CM tabular list, indicating the need to report the organism code as a secondary code?

    Responses

    – Cross reference

    – Code also

    – Use additional code

    – Excludes1

    7) The "code, if applicable, any causal condition first" note in the ICD-10-CM tabular lists indicates that this code may be assigned as a first-listed or principal diagnosis when the causal condition is unknown or not applicable. When the causal condition is known, the code for that condition should be reported as the __________ diagnosis.

    Responses

    – qualified

    – manifestation

    – comorbidity

    – principal

    8) For the diagnosis rheumatic pneumonia, report ICD-10-CM code(s)

    Responses

    – J17, I00.

    – I00, J17.

    – J17.

    – I00.

    9) When the same condition is described as both acute (or subacute) and chronic and separate subentries exist in the ICD-10-CM index at the same indentation level,

    Responses

    – assign codes for both and list the chronic condition first.

    – code both and sequence the acute (or subacute) code first.

    – report a code for the acute (or subacute) condition only.

    – generate a physician query to ask which condition is coded.

    10) For acute cholecystitis and cholelithiasis, assign ICD-10-CM code

    Responses

    – K80.62.

    – K80.00.

    – K80.10.

    – K80.12.

    11) For a diagnosis of headaches due to intracranial injury without loss of consciousness that occurred several years ago, which is considered the sequela (residual condition)?

    Responses

    – Headaches

    – Intracranial injury

    – Loss of consciousness

    – None of these

    12) ICD-10-CM codes that indicate laterality specify whether the condition occurs

    Responses

    – as a residual or current condition.

    – on the left, right, or bilaterally.

    – in the hospital or as an outpatient.

    – acutely or chronically.

    13) When assigning codes for a syndrome, follow guidance in the

    Responses

    – third-party payer policy.

    – official coding guidelines.

    – patient record

    – ICD-10-CM index.

    14) How are etiology and manifestation codes reported in the ICD-10-CM?

    Responses

    – Etiology code is printed in slanted (or square) brackets in the index.

    – Manifestation code is sequenced first, followed by the etiology code.

    – Manifestation code defines the underlying condition or disease.

    – Etiology code is reported first, followed by the manifestation code.

    15) The "see also" instruction in ICD-10-CM

    Responses

    – does not have to be followed if the original main term provides the correct code.

    .

    – must always be followed for disease codes to be assigned properly.

    – is considered a mandatory guideline in the index.

    – appears in the tabular list and is an optional guideline.

    16) Which information must be included in the diagnostic statement to classify a condition in the ICD-10-CM tabular list?

    Responses

    – Synonyms enclosed in square brackets

    – Inclusion terms

    – Modifying term(s) located after the colon

    – Nonessential modifiers enclosed in parentheses

    17) A patient is diagnosed with amyloid heart (disease). Codes E85.4 [I43] are located in the ICD-10-CM Index to Disease and Injuries. Upon verification in the Tabular List of Diseases and Injuries, report code(s)

    Responses

    – I43 and E85.4, in that order.

    – E85.4 and I43, in that order.

    – E85.4 only.

    – I43 only.

    18) he description for code J00 in the ICD-10-CM Tabular List of Diseases and Injuries is "acute nasopharyngitis [common cold]." How is this code description interpreted?

    Responses

    – Acute nasopharyngitis due to common cold

    – Acute nasopharyngitis with common cold

    – Common cold due to acute nasopharyngitis

    – Acute nasopharyngitis and common cold are synonymous.

    19) The concept "trust the index" in the ICD-10-CM disease index means that when

    Responses

    – all terms that apply to a particular code will be listed in the tabular list code description; thus, if there is no inclusion term for that condition, the code cannot be assigned.

    – exclusion terms located in the disease index are not meant to be exhaustive, and additional terms found in the tabular list may also be associated with a code.

    – the term has been used to correctly locate a code in the disease index and the code listed in the index contains additional characters, it is not necessary to verify the code in the tabular list.

    – a term has been used to correctly locate a code in the disease index, but that term is not described in the tabular list code entry, trust that the index directed you to the correct code.

    20) Which instruction in the ICD-10-CM tabular list allows only one code to be reported if a secondary condition is not documented?

    Responses

    – Code first underlying condition

    – Code, if applicable, any causal condition first

    – Use additional code

    – In diseases classified elsewhere

    **## WK3QUESTIONSHP-212.odt**

    ## Thumbnails/thumbnail.png

    1) To initially locate an ICD-10-CM external causes code, go to the

    Responses

    – Index to External Cause of Injuries.

    – Index to Diseases and Injuries.

    – Index to Procedures.

    – Table of Drugs and Chemicals.

    2) Persons with unavailability and inaccessibility of health care facilities" is an example of a(n)

    Responses

    – separate index in the ICD-10-CM coding manual.

    – section in the HCPCS level II coding system.

    – chapter of Z codes in ICD-10-CM.

    – ICD-10-CM grouping of external causes codes.

    3) Which set of codes is used to report how an injury or condition happened, the intent, the place of occurrence, the activity of the patient at the time of the event, and the person's status?

    Responses

    – ICD-10-CM signs and symptoms codes

    – ICD-10-CM Z codes

    – ICD-10-CM external causes codes

    – A separate index in ICD-10-CM

    4) The ICD-10-CM Tabular List of Diseases and Injuries is referenced

    Responses

    – if the phrase "omit code" is included in the index.

    – for verification of external causes codes only.

    – when a procedure code is listed as unspecified.

    – to verify codes selected and to review instructions.

    5) The patient is treated for diabetes mellitus controlled by medication, and during the same encounter, he tells the physician that he has been experiencing severe indigestion. The physician discussed possible reasons for indigestion with the patient, who admitted to having eaten a lot of spicy foods in the past month. The patient is unwilling to take over-the-counter or prescription medications for the indigestion, and the physician suggested alternative solutions. The physician also instructed the patient to return in two weeks for follow-up of the indigestion. To completely code this case, assign ICD-10-CM code(s) for

    Responses

    – diabetes mellitus, indigestion.

    – diabetes mellitus.

    – indigestion.

    – diabetes mellitus, chest pain.

    6) Which type of note is usually found below the infectious disease code in the ICD-10-CM tabular list, indicating the need to report the organism code as a secondary code?

    Responses

    – Cross reference

    – Code also

    – Use additional code

    – Excludes1

    7) The "code, if applicable, any causal condition first" note in the ICD-10-CM tabular lists indicates that this code may be assigned as a first-listed or principal diagnosis when the causal condition is unknown or not applicable. When the causal condition is known, the code for that condition should be reported as the __________ diagnosis.

    Responses

    – qualified

    – manifestation

    – comorbidity

    – principal

    8) For the diagnosis rheumatic pneumonia, report ICD-10-CM code(s)

    Responses

    – J17, I00.

    – I00, J17.

    – J17.

    – I00.

    9) When the same condition is described as both acute (or subacute) and chronic and separate subentries exist in the ICD-10-CM index at the same indentation level,

    Responses

    – assign codes for both and list the chronic condition first.

    – code both and sequence the acute (or subacute) code first.

    – report a code for the acute (or subacute) condition only.

    – generate a physician query to ask which condition is coded.

    10) For acute cholecystitis and cholelithiasis, assign ICD-10-CM code

    Responses

    – K80.62.

    – K80.00.

    – K80.10.

    – K80.12.

    11) For a diagnosis of headaches due to intracranial injury without loss of consciousness that occurred several years ago, which is considered the sequela (residual condition)?

    Responses

    – Headaches

    – Intracranial injury

    – Loss of consciousness

    – None of these

    12) ICD-10-CM codes that indicate laterality specify whether the condition occurs

    Responses

    – as a residual or current condition.

    – on the left, right, or bilaterally.

    – in the hospital or as an outpatient.

    – acutely or chronically.

    13) When assigning codes for a syndrome, follow guidance in the

    Responses

    – third-party payer policy.

    – official coding guidelines.

    – patient record

    – ICD-10-CM index.

    14) How are etiology and manifestation codes reported in the ICD-10-CM?

    Responses

    – Etiology code is printed in slanted (or square) brackets in the index.

    – Manifestation code is sequenced first, followed by the etiology code.

    – Manifestation code defines the underlying condition or disease.

    – Etiology code is reported first, followed by the manifestation code.

    15) The "see also" instruction in ICD-10-CM

    Responses

    – does not have to be followed if the original main term provides the correct code.

    .

    – must always be followed for disease codes to be assigned properly.

    – is considered a mandatory guideline in the index.

    – appears in the tabular list and is an optional guideline.

    16) Which information must be included in the diagnostic statement to classify a condition in the ICD-10-CM tabular list?

    Responses

    – Synonyms enclosed in square brackets

    – Inclusion terms

    – Modifying term(s) located after the colon

    – Nonessential modifiers enclosed in parentheses

    17) A patient is diagnosed with amyloid heart (disease). Codes E85.4 [I43] are located in the ICD-10-CM Index to Disease and Injuries. Upon verification in the Tabular List of Diseases and Injuries, report code(s)

    Responses

    – I43 and E85.4, in that order.

    – E85.4 and I43, in that order.

    – E85.4 only.

    – I43 only.

    18) he description for code J00 in the ICD-10-CM Tabular List of Diseases and Injuries is "acute nasopharyngitis [common cold]." How is this code description interpreted?

    Responses

    – Acute nasopharyngitis due to common cold

    – Acute nasopharyngitis with common cold

    – Common cold due to acute nasopharyngitis

    – Acute nasopharyngitis and common cold are synonymous.

    19) The concept "trust the index" in the ICD-10-CM disease index means that when

    Responses

    – all terms that apply to a particular code will be listed in the tabular list code description; thus, if there is no inclusion term for that condition, the code cannot be assigned.

    – exclusion terms located in the disease index are not meant to be exhaustive, and additional terms found in the tabular list may also be associated with a code.

    – the term has been used to correctly locate a code in the disease index and the code listed in the index contains additional characters, it is not necessary to verify the code in the tabular list.

    – a term has been used to correctly locate a code in the disease index, but that term is not described in the tabular list code entry, trust that the index directed you to the correct code.

    20) Which instruction in the ICD-10-CM tabular list allows only one code to be reported if a secondary condition is not documented?

    Responses

    – Code first underlying condition

    – Code, if applicable, any causal condition first

    – Use additional code

    – In diseases classified elsewhere

  • [Solved] WK3 ASSIGNMENT HP-212

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    COMPLETE ALL QUESTIONS – ## WK3ASSIGNMENTHP-212.odt **## WK3ASSIGNMENTHP-212.odt** ## Thumbnails/thumbnail.png 1) The ICD-10-CM Official Guidelines for Coding and Reporting are approved by the FILL IN BLANK parties for ICD-10-CM to accompany and complement the official conventions and instructions p…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    COMPLETE ALL QUESTIONS

    – ## WK3ASSIGNMENTHP-212.odt

    **## WK3ASSIGNMENTHP-212.odt**

    ## Thumbnails/thumbnail.png

    1) The ICD-10-CM Official Guidelines for Coding and Reporting are approved by the FILL IN BLANK

    parties for ICD-10-CM to accompany and complement the official conventions and instructions provided within ICD-10-CM.

    2) Official coding guidelines use the term FILL IN BLANK

    when referring to face-to-face contact between patients and health care providers in all health care settings, including inpatient hospital admissions.

    3) Official coding guidelines use the term FILL IN BLANK

    when referring to a physician or any qualified health care practitioner who is legally accountable for establishing a patient's diagnosis.

    4) HIPAA regulations for electronic FILL IN BLANK

    require providers and third-party payers, including Medicare Administrative Contractors (MACs), to adhere to ICD-10-CM Official Guidelines for Coding and Reporting.

    5) Section I of the ICD-10-CM Official Guidelines for Coding and Reporting includes ICD-10-CM's coding FILL IN BLANK

    , general coding guidelines, and chapter-specific guidelines.

    6) Section II of the ICD-10-CM Official Guidelines for Coding and Reporting covers selection of the FILL IN BLANK

    diagnosis (and secondary diagnoses) for inpatient hospital admissions.

    7) Section III of the ICD-10-CM Official Guidelines for Coding and Reporting covers reporting of additional diagnoses for inpatient hospital settings, which are also called FILL IN BLANK

    diagnoses and include comorbidities and complications.

    8) Inpatient hospital admissions require the reporting of secondary diagnoses that include comorbidities and FILL IN BLANK

    9) Section IV of the ICD-10-CM Official Guidelines for Coding and Reporting covers diagnostic coding and reporting for FILL IN BLANK services

    10) Appendix I of the ICD-10-CM Official Guidelines for Coding and Reporting covers present on  FILL IN BLANK  reporting guidelines.

    11) Patient admitted for difficulty breathing and fever. Physician's discharge diagnosis is pneumonia.

    12) Patient admitted with malaise. Physician's discharge diagnosis is depression.

    FILL IN BLANK

    13) Patient admitted with severe headache. Physician's discharge diagnosis is intractable migraine. FILL IN BLANK

    14) Patient admitted with abdominal pain and fever. Physician's discharge diagnosis is acute appendicitis. FILL IN BLANK

    15) Patient admitted with pain and swelling, left ankle. Physician's discharge diagnosis is sprain, left ankle, initial encounter. FILL IN BLANK

    16) Acute cholecystitis with nausea, vomiting, and fever FILL IN BLANK

    17) Chronic tonsillitis and adenoiditis FILL IN BLANK

    18) Acute cystitis with hematuria due to Escherichia coli

    , FILL IN BLANKS 2 ANSWERS

    19) Multisystem inflammatory syndrome (MIS) as post-acute sequela of COVID-19 FILL IN BLANKS 2 ANSWERS

    20) Admission for adjustment of left partial artificial leg FILL IN BLANK

    **## WK3ASSIGNMENTHP-212.odt**

    ## Thumbnails/thumbnail.png

    1) The ICD-10-CM Official Guidelines for Coding and Reporting are approved by the FILL IN BLANK

    parties for ICD-10-CM to accompany and complement the official conventions and instructions provided within ICD-10-CM.

    2) Official coding guidelines use the term FILL IN BLANK

    when referring to face-to-face contact between patients and health care providers in all health care settings, including inpatient hospital admissions.

    3) Official coding guidelines use the term FILL IN BLANK

    when referring to a physician or any qualified health care practitioner who is legally accountable for establishing a patient's diagnosis.

    4) HIPAA regulations for electronic FILL IN BLANK

    require providers and third-party payers, including Medicare Administrative Contractors (MACs), to adhere to ICD-10-CM Official Guidelines for Coding and Reporting.

    5) Section I of the ICD-10-CM Official Guidelines for Coding and Reporting includes ICD-10-CM's coding FILL IN BLANK

    , general coding guidelines, and chapter-specific guidelines.

    6) Section II of the ICD-10-CM Official Guidelines for Coding and Reporting covers selection of the FILL IN BLANK

    diagnosis (and secondary diagnoses) for inpatient hospital admissions.

    7) Section III of the ICD-10-CM Official Guidelines for Coding and Reporting covers reporting of additional diagnoses for inpatient hospital settings, which are also called FILL IN BLANK

    diagnoses and include comorbidities and complications.

    8) Inpatient hospital admissions require the reporting of secondary diagnoses that include comorbidities and FILL IN BLANK

    9) Section IV of the ICD-10-CM Official Guidelines for Coding and Reporting covers diagnostic coding and reporting for FILL IN BLANK services

    10) Appendix I of the ICD-10-CM Official Guidelines for Coding and Reporting covers present on  FILL IN BLANK  reporting guidelines.

    11) Patient admitted for difficulty breathing and fever. Physician's discharge diagnosis is pneumonia.

    12) Patient admitted with malaise. Physician's discharge diagnosis is depression.

    FILL IN BLANK

    13) Patient admitted with severe headache. Physician's discharge diagnosis is intractable migraine. FILL IN BLANK

    14) Patient admitted with abdominal pain and fever. Physician's discharge diagnosis is acute appendicitis. FILL IN BLANK

    15) Patient admitted with pain and swelling, left ankle. Physician's discharge diagnosis is sprain, left ankle, initial encounter. FILL IN BLANK

    16) Acute cholecystitis with nausea, vomiting, and fever FILL IN BLANK

    17) Chronic tonsillitis and adenoiditis FILL IN BLANK

    18) Acute cystitis with hematuria due to Escherichia coli

    , FILL IN BLANKS 2 ANSWERS

    19) Multisystem inflammatory syndrome (MIS) as post-acute sequela of COVID-19 FILL IN BLANKS 2 ANSWERS

    20) Admission for adjustment of left partial artificial leg FILL IN BLANK

  • [Solved] Explain the use of evidence-based practice by leaders and managers?

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    In-depth study guidance and analytical solution covering Explain the use of evidence-based practice by leaders and managers?.

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Full assignment prompt and step-by-step guidance are included in the downloadable solution file.

  • [Solved] NUR506W6A

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    – ## NUR506W6A.docx **## NUR506W6A.docx** The goal of this assignment is to familiarize students with interest groups. Please follow the steps below to complete your assignment. 1. **Select** an interest group (AARP, AHIP, Coalition for Health Services Research, Emergency Nurses Association, Pharma…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    – ## NUR506W6A.docx

    **## NUR506W6A.docx**

    The goal of this assignment is to familiarize students with interest groups. Please follow the steps below to complete your assignment.

    1.
    **Select** an interest group (AARP, AHIP, Coalition for Health Services Research, Emergency Nurses Association, Pharma)

    2.
    **Discuss** how they are pushing their agenda (i.e., mechanisms used to influence policy makers), key obstacles, and spending (consult the Center for Responsible Politics, www.opensecrets.org)

    3.
    **Investigate** the interest group’s website and review their position statements, testimony, and consult media reports to obtain more information on the group’s lobbying efforts.

    **Submission Requirements:**

    · Presentation is original work and logically organized. Followed current APA format including citation of references.

    · PowerPoint presentation with 5-8 slides were clear and easy to read. Speaker notes expanded upon and clarified content on the slides.

    · Incorporate a minimum of 4 current (published within last five years) scholarly journal articles or primary legal sources (statutes, court opinions) within your work.

    · Journal articles and books should be referenced according to current APA style.

    RUBRIC:

    ![A screenshot of a computer AI-generated content may be incorrect.](https://www.sweetstudy.com/questions/nur506w6a)

    ## image1.png

    **## NUR506W6A.docx**

    The goal of this assignment is to familiarize students with interest groups. Please follow the steps below to complete your assignment.

    1.
    **Select** an interest group (AARP, AHIP, Coalition for Health Services Research, Emergency Nurses Association, Pharma)

    2.
    **Discuss** how they are pushing their agenda (i.e., mechanisms used to influence policy makers), key obstacles, and spending (consult the Center for Responsible Politics, www.opensecrets.org)

    3.
    **Investigate** the interest group’s website and review their position statements, testimony, and consult media reports to obtain more information on the group’s lobbying efforts.

    **Submission Requirements:**

    · Presentation is original work and logically organized. Followed current APA format including citation of references.

    · PowerPoint presentation with 5-8 slides were clear and easy to read. Speaker notes expanded upon and clarified content on the slides.

    · Incorporate a minimum of 4 current (published within last five years) scholarly journal articles or primary legal sources (statutes, court opinions) within your work.

    · Journal articles and books should be referenced according to current APA style.

    RUBRIC:

    ![A screenshot of a computer AI-generated content may be incorrect.](https://www.sweetstudy.com/questions/nur506w6a)

    ## image1.png

  • [Solved] 612 soap 3

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    – ## 612clinicalsoap3.docx – ## SOAPNOTETEMPLATEBLANK.docx – SOAPNoteRubric.pdf **## 612clinicalsoap3.docx** ![icon](https://www.sweetstudy.com/questions/612-soap-3)**_SOAP Note 3_** A SOAP note is a method of documentation employed by healthcare providers to record and communicate patient informati…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    – ## 612clinicalsoap3.docx

    – ## SOAPNOTETEMPLATEBLANK.docx

    – SOAPNoteRubric.pdf

    **## 612clinicalsoap3.docx**

    ![icon](https://www.sweetstudy.com/questions/612-soap-3)**_SOAP Note 3_**

    A SOAP note is a method of documentation employed by healthcare providers to record and communicate patient information in a clear, structured, and in an organized manner. This assignment will provide students with the necessary tools to document patient care effectively, enhance their clinical skills, and prepare them for their roles as competent healthcare providers.

    **Instructions:**

    SOAP is an acronym that stands for Subjective, Objective, Assessment, and Plan. The episodic SOAP note is to be written using the attached template below.

    For all the SOAP note assignments, you will write a SOAP note about one of your patients and use the following acronym:

    | | |
    | — | — |
    | **S** = | Subjective data: Patient’s Chief Complaint (CC). |
    | **O** = | Objective data: Including client behavior, physical assessment, vital signs, and meds. |
    | **A** = | Assessment: Diagnosis of the patient's condition. Include differential diagnosis. |
    | **P** = | Plan: Treatment, diagnostic testing, and follow up |

    [Click here to access and download the SOAP Note Template](https://stu.instructure.com/courses/45516/files/3584005?wrap=1) [Download Click here to access and download the SOAP Note Template](https://stu.instructure.com/courses/45516/files/3584005/download?download_frd=1)

    **Submission Instructions:**

    · Your SOAP note should be clear and concise and students will lose points for improper grammar, punctuation, and misspellings.

    · You must use the template provided. Turnitin will recognize the template and not score against it.

    ## image1.png

    **## SOAPNOTETEMPLATEBLANK.docx**

    | | |
    | — | — |
    | SOAP NOTE TEMPLATE<br>Review the Rubric for more Guidance |
    | _Demographics_ | |
    | _Chief Complaint (Reason for seeking health care)_ | |
    | _History of Present Illness (HPI)_ | |
    | _Allergies_ | |
    | _Review of Systems (ROS)_ | General: <br>HEENT:<br>Neck: <br>Lungs:<br>Cardio<br>Breast: <br>GI: <br>M/F genital:<br>GU: <br>Neuro<br>Musculo:<br>Activity:<br>Psychosocial: <br>Derm: <br>Nutrition:<br>Sleep/Rest:<br>LMP: <br>STI Hx: |
    | _Vital Signs_ | |
    | _Labs_ | |
    | _Medications_ | |
    | _Past Medical History_ | |
    | _Past Surgical History_ | |
    | _Family History_ | |
    | _Social History_ | |
    | _Health Maintenance/ Screenings_ | |
    | _Physical Examination_ | General: <br>HEENT:<br>Neck: <br>Lungs:<br>Cardio<br>Breast: <br>GI: <br>M/F genital:<br>GU: <br>Neuro<br>Musculo:<br>Activity:<br>Psychosocial: <br>Derm: |
    | _Diagnosis_ | |
    | _Differential Diagnosis_ | |
    | _ICD 10 Coding_ | |
    | _Pharmacologic treatment plan_ | |
    | _Diagnostic/Lab Testing_ | |
    | _Education_ | |
    | _Anticipatory Guidance_ | |
    | _Follow up plan_ | |
    | _Prescription_ | See Below (scroll down) |
    | _References_ | |
    | _Grammar_ | |

    | |
    | — |
    | EA#: 101010101 STU Clinic LIC# 10000000 |
    | Tel: (000) 555-1234 FAX: (000) 555-12222 |
    | Patient Name: (Initials)______________________________ Age ___________<br>Date: _______________<br>RX ______________________________________<br>SIG:<br>Dispense: ___________ Refill: _________________<br>No Substitution<br> <br>Signature:____________________________________________________________ |

    Signature (with appropriate credentials):_____________________________________

    References (must use current evidence-based guidelines used to guide the care [Mandatory])

    **SOAPNoteRubric.pdf**

    This file is too large to display. [View in new window](https://www.sweetstudy.com/files/soapnoterubric-pdf-10332763)

    **SOAPNoteRubric.pdf**

    This file is too large to display. [View in new window](https://www.sweetstudy.com/files/soapnoterubric-pdf-10332763)

    **## 612clinicalsoap3.docx**

    ![icon](https://www.sweetstudy.com/questions/612-soap-3)**_SOAP Note 3_**

    A SOAP note is a method of documentation employed by healthcare providers to record and communicate patient information in a clear, structured, and in an organized manner. This assignment will provide students with the necessary tools to document patient care effectively, enhance their clinical skills, and prepare them for their roles as competent healthcare providers.

    **Instructions:**

    SOAP is an acronym that stands for Subjective, Objective, Assessment, and Plan. The episodic SOAP note is to be written using the attached template below.

    For all the SOAP note assignments, you will write a SOAP note about one of your patients and use the following acronym:

    | | |
    | — | — |
    | **S** = | Subjective data: Patient’s Chief Complaint (CC). |
    | **O** = | Objective data: Including client behavior, physical assessment, vital signs, and meds. |
    | **A** = | Assessment: Diagnosis of the patient's condition. Include differential diagnosis. |
    | **P** = | Plan: Treatment, diagnostic testing, and follow up |

    [Click here to access and download the SOAP Note Template](https://stu.instructure.com/courses/45516/files/3584005?wrap=1) [Download Click here to access and download the SOAP Note Template](https://stu.instructure.com/courses/45516/files/3584005/download?download_frd=1)

    **Submission Instructions:**

    · Your SOAP note should be clear and concise and students will lose points for improper grammar, punctuation, and misspellings.

    · You must use the template provided. Turnitin will recognize the template and not score against it.

    ## image1.png

    **## SOAPNOTETEMPLATEBLANK.docx**

    | | |
    | — | — |
    | SOAP NOTE TEMPLATE<br>Review the Rubric for more Guidance |
    | _Demographics_ | |
    | _Chief Complaint (Reason for seeking health care)_ | |
    | _History of Present Illness (HPI)_ | |
    | _Allergies_ | |
    | _Review of Systems (ROS)_ | General: <br>HEENT:<br>Neck: <br>Lungs:<br>Cardio<br>Breast: <br>GI: <br>M/F genital:<br>GU: <br>Neuro<br>Musculo:<br>Activity:<br>Psychosocial: <br>Derm: <br>Nutrition:<br>Sleep/Rest:<br>LMP: <br>STI Hx: |
    | _Vital Signs_ | |
    | _Labs_ | |
    | _Medications_ | |
    | _Past Medical History_ | |
    | _Past Surgical History_ | |
    | _Family History_ | |
    | _Social History_ | |
    | _Health Maintenance/ Screenings_ | |
    | _Physical Examination_ | General: <br>HEENT:<br>Neck: <br>Lungs:<br>Cardio<br>Breast: <br>GI: <br>M/F genital:<br>GU: <br>Neuro<br>Musculo:<br>Activity:<br>Psychosocial: <br>Derm: |
    | _Diagnosis_ | |
    | _Differential Diagnosis_ | |
    | _ICD 10 Coding_ | |
    | _Pharmacologic treatment plan_ | |
    | _Diagnostic/Lab Testing_ | |
    | _Education_ | |
    | _Anticipatory Guidance_ | |
    | _Follow up plan_ | |
    | _Prescription_ | See Below (scroll down) |
    | _References_ | |
    | _Grammar_ | |

    | |
    | — |
    | EA#: 101010101 STU Clinic LIC# 10000000 |
    | Tel: (000) 555-1234 FAX: (000) 555-12222 |
    | Patient Name: (Initials)______________________________ Age ___________<br>Date: _______________<br>RX ______________________________________<br>SIG:<br>Dispense: ___________ Refill: _________________<br>No Substitution<br> <br>Signature:____________________________________________________________ |

    Signature (with appropriate credentials):_____________________________________

    References (must use current evidence-based guidelines used to guide the care [Mandatory])

    **SOAPNoteRubric.pdf**

    This file is too large to display. [View in new window](https://www.sweetstudy.com/files/soapnoterubric-pdf-10332763)

    **## 612clinicalsoap3.docx**

    ![icon](https://www.sweetstudy.com/questions/612-soap-3)**_SOAP Note 3_**

    A SOAP note is a method of documentation employed by healthcare providers to record and communicate patient information in a clear, structured, and in an organized manner. This assignment will provide students with the necessary tools to document patient care effectively, enhance their clinical skills, and prepare them for their roles as competent healthcare providers.

    **Instructions:**

    SOAP is an acronym that stands for Subjective, Objective, Assessment, and Plan. The episodic SOAP note is to be written using the attached template below.

    For all the SOAP note assignments, you will write a SOAP note about one of your patients and use the following acronym:

    | | |
    | — | — |
    | **S** = | Subjective data: Patient’s Chief Complaint (CC). |
    | **O** = | Objective data: Including client behavior, physical assessment, vital signs, and meds. |
    | **A** = | Assessment: Diagnosis of the patient's condition. Include differential diagnosis. |
    | **P** = | Plan: Treatment, diagnostic testing, and follow up |

    [Click here to access and download the SOAP Note Template](https://stu.instructure.com/courses/45516/files/3584005?wrap=1) [Download Click here to access and download the SOAP Note Template](https://stu.instructure.com/courses/45516/files/3584005/download?download_frd=1)

    **Submission Instructions:**

    · Your SOAP note should be clear and concise and students will lose points for improper grammar, punctuation, and misspellings.

    · You must use the template provided. Turnitin will recognize the template and not score against it.

    ## image1.png

    **## SOAPNOTETEMPLATEBLANK.docx**

    | | |
    | — | — |
    | SOAP NOTE TEMPLATE<br>Review the Rubric for more Guidance |
    | _Demographics_ | |
    | _Chief Complaint (Reason for seeking health care)_ | |
    | _History of Present Illness (HPI)_ | |
    | _Allergies_ | |
    | _Review of Systems (ROS)_ | General: <br>HEENT:<br>Neck: <br>Lungs:<br>Cardio<br>Breast: <br>GI: <br>M/F genital:<br>GU: <br>Neuro<br>Musculo:<br>Activity:<br>Psychosocial: <br>Derm: <br>Nutrition:<br>Sleep/Rest:<br>LMP: <br>STI Hx: |
    | _Vital Signs_ | |
    | _Labs_ | |
    | _Medications_ | |
    | _Past Medical History_ | |
    | _Past Surgical History_ | |
    | _Family History_ | |
    | _Social History_ | |
    | _Health Maintenance/ Screenings_ | |
    | _Physical Examination_ | General: <br>HEENT:<br>Neck: <br>Lungs:<br>Cardio<br>Breast: <br>GI: <br>M/F genital:<br>GU: <br>Neuro<br>Musculo:<br>Activity:<br>Psychosocial: <br>Derm: |
    | _Diagnosis_ | |
    | _Differential Diagnosis_ | |
    | _ICD 10 Coding_ | |
    | _Pharmacologic treatment plan_ | |
    | _Diagnostic/Lab Testing_ | |
    | _Education_ | |
    | _Anticipatory Guidance_ | |
    | _Follow up plan_ | |
    | _Prescription_ | See Below (scroll down) |
    | _References_ | |
    | _Grammar_ | |

    | |
    | — |
    | EA#: 101010101 STU Clinic LIC# 10000000 |
    | Tel: (000) 555-1234 FAX: (000) 555-12222 |
    | Patient Name: (Initials)______________________________ Age ___________<br>Date: _______________<br>RX ______________________________________<br>SIG:<br>Dispense: ___________ Refill: _________________<br>No Substitution<br> <br>Signature:____________________________________________________________ |

    Signature (with appropriate credentials):_____________________________________

    References (must use current evidence-based guidelines used to guide the care [Mandatory])

    **SOAPNoteRubric.pdf**

    This file is too large to display. [View in new window](https://www.sweetstudy.com/files/soapnoterubric-pdf-10332763)

    – 1
    – 2
    – 3

  • [Solved] Identify collaborative opportunities for health promotion, risk reduction, and disease prevention?.

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    In-depth study guidance and analytical solution covering Identify collaborative opportunities for health promotion, risk reduction, and disease prevention?..

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Full assignment prompt and step-by-step guidance are included in the downloadable solution file.